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ABSTRACT

MODULATION OF NEUTROPHIL FUNCTIONS BY NEUROTRANSMITTERS
IMPUCATED IN STRESS

by
Chok Ping Wan

Stress has long been implicated in immune modulation. People under chronic
stress have no change in the circulating basal levels of catecholamines while plasma
levels of neuropeptide Y (NPY) are significantly increased. Sympathetic nerve fibers
with NPY have been found to innervate immune organs. It was hypothesized that
NPY might be a mediator in immune modulation in people under chronic stress.
Human neutrophils were used as a model to study the effects of NPY alone or
together with norepinephrine on the immune system. We now report that NPY
modulates oxidative burst (OB) triggered by zymosan in human neutrophils while it
has no effects on the phagocytosis process. NPY did not trigger but did enhance OB
in a time and dose-dependent fashion. The reaction was specific since non-specific
peptides did not produce any significant effects, and anti-NPY antibody essentially
neutralized this enhancement while antibody which was non-specific for NPY did not
block the modulation. The enhancement of OB was not due to a general activation of
metabolism of the neutrophils since the cytosolic non-specific esterases (measured by
calcein-AM), the mitochondrial dehydrogenases (measured by

3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide), and oxygen
consumption were not affected by NPY. NPY may be an important link in
neuro-immune modulation under chronic stress. Modulation of neutrophil OB by
NPY is likely to involve an atypical receptor that has not been described in the
literature since peptide YY, [Leu31,Pro34]NPY, and NPY C-terminal fragment 13-36
induced comparable responses to NPY and none of the known receptor antagonists
could block the NPY-induced modulation. Synthesis of macromolecules is probably
not involved in the modulation process since cycloheximide (a protein synthesis
inhibitor) and 5,6-dichlorobenzimidazole riboside (an RNA synthesis inhibitor) did not
block the modulation. NPY enhanced the OB triggered by zymosan and
N-formyl-Met-Leu-Phe, but not by phorbal myristate acetate. This indicated that the
modulation does not involve protein kinase C or NADPH-oxidase. Compound
R24571 (a calmodulin inhibitor) did not affect the oxidative burst process or inhibit
the NPY modulation, indicating that Ca++/calmodulin dependent enzymes are not
involved in the modulation process.
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2
O’Dorisio, 1991), and cytokines, that interact with receptors found on cells of both
systems (Carr & Blalock, 1991). These mediators utilize common second messenger
systems (Hadden et al., 1991), probably interacting either directly or indirectly to
alter the responsiveness of receptor expression for these signal molecules, providing
for integrated responses when acting on neurons or lymphocytes.

Neuropeptide Y (NPY), originally isolated from porcine brain (Tatemoto et al.,
1982; Tatemoto, 1982), is a 36-amino acid peptide. This neuropeptide has been
implicated in mediating many functions in peripheral tissues (Table I) and in central
nervous system (Table n). It is often found closely associated with or stored in
catecholamine-containing neurons of the autonomic nervous system (Lundberg et al.,
1982; 1983). NPY is released during stimulation of sympathetic nerves in laboratory
animals (Castagne et al., 1987; Zukowska-Grojec et al., 1988) and during exercise or
stress tests in humans (Lundberg et al., 1985), especially those of high intensity.
Circulating concentrations of NPY were markedly raised above the normal range in
patients with septic shock, although no increase was observed in dogs with endotoxin
shock (Watson et al., 1988). Plasma levels of NPY, but not circulating basal levels
of catecholamines, were significantly elevated in the depressed patients and the
Alzheimer caregivers (Irwin et al., 1991). This observation points to a correlation
between chronic stress and NPY levels.

3

TABLE I.
PERIPHERAL NEUROPEPTIDE Y TARGET TISSUES
1. Blood vessels (vasoconstriction)

9. Islet 0 cells (insulin)

2. Heart (chronotropy; inotropy)

10. Thyroid gland

3. Airways

11. Sympathetic nerves

4. Large intestine (motility)

12. Parasympathetic nerves

5. Small intestine (secretion & motility)

13. Sensory nerves

6. Kidney (collecting tubule)

14. Endothelial cells

7. Juxtaglomerular cells (renin)

15. Platelets

8. Atrial cardiocytes (ANF)

16. Mast cells

“Adopted from Wahlestedt et al., 1990. For references, see Allen & Koenig, 1990.

7

NPY blockers may similarly reverse some of the adverse effects of stress on the
immune system in a clinical setting (Tatemoto, 1990; Li et al., 1991).
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SUMMARY

Neuropeptide Y (NPY) is an amidated 36-amino acid peptide with a wide
distribution in the central and peripheral nervous system. It can evoke numerous
physiological responses by activating specific receptors. Studies using NPY analogs
in various model systems and cell types demonstrate different orders of ligand potency
and receptor binding affinity. These studies suggest the existence of multiple
subtypes of NPY receptors. NPY has been described to bind to at least three
different receptors, Yj, Y2 and Y3. NPY has also been shown to interact with sigma
receptor in vivo and in vitro. There are indications that more subtypes might exist.
Ligand binding studies reveal that Y1? Y2 and Y3 receptors are all G-protein coupled.
It is not yet confirmed whether the sigma receptor that interacts with NPY is
G-protein coupled. Some studies show that NPY receptors may interact with other
classical receptors, including a- and 0-adrenoceptors and cholinergic receptors. In
the case of a- and ^-adrenoceptors, the receptor-receptor interaction is possibly via a
pertussis toxin-sensitive G-protein. NPY receptors are coupled to various signal
transduction mechanisms including inhibition of adenylate cyclase, and stimulation or
inhibition of increases in intracellular Ca2+. Specific links between individual NPY
receptor subtype and a particular signal transduction pathway are not established.
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INTRODUCTION

Neuropeptide Y (NPY) is a 36 amino acid peptide with a C-terminal tyrosylamide, denoted by the "Y" in the name. It was first isolated from porcine brain
(Tatmoto et al., 1982) and sequenced (Tatemoto, 1982) in 1982. The primary
structure of NPY is well conserved among different species. Human and porcine
NPY are structurally identical except for residue 17 (methionine in human, leucine in
porcine). The peptide belongs together with peptide YY (PYY; approximately 70%
homology) and pancreatic polypeptide (PP; approximately 50% homology) to the
so-called pancreatic polypeptide-fold peptide family (Tatemoto, 1982).

This PP-fold family of peptides is characterized by a common tertiary structure
which is stable even in dilute aqueous solutions. The tertiary structure of NPY
consists of an N-terminal polyproline sequence (residues 2-8) and an amphiphilic
cx-helix (residues 14-32) connected with each other a type I /3-tum, creating a hairpinlike loop (the so-called PP-fold). The helices are held together by interdigitating
hydrophobic side chains, and the C-terminal end projects away from the hairpin loop
at a 90° angle (Allen et al., 1987). The hairpin-like loop may serve to bring the
N- and C-termini of NPY in close apposition, thereby enabling the receptor to
recognize the signal epitopes of the ligand (Schwartz et al., 1990). The C-terminal
segment is very similar among the PP-fold peptides, and the C-terminal amide is

17
NPY is probably one of the most studied peptides since its discovery in 1982. A
literature review shows that thousands of research articles, many review papers and a
number of books related to this peptide have been published. Regarding its receptors,
the Yj, Y2 and Y3 receptors have been discussed in previous reviews which provide
the historical development in their discovery (Grundemar & Hakanson, 1993; Michel,
1991; Wahlestedt et al., 1990). We now give an update on the receptor subtypes and
their associated properties. There are indications that more receptor types might
exist. Table I summarizes the recent development. The superscripts in parentheses
denote the references.

Y, Receptor

The existence of multiple receptor subtypes was first proposed by Wahlestedt
et al. (1986). In the initial model systems, the post-junctional effect of
vasoconstriction could only be obtained with the intact NPY and PYY molecules,
whereas a long C-terminal fragment, PYY 13-365 was sufficient to elicit pre-junctional
inhibition of stimulated norepinephrine release (Wahlestedt et al., 1986). These
observations were confirmed by others using NPY13.36 The term Yj was proposed for
receptors with a low affinity for C-terminal fragments of NPY and Y2 for receptors
with a high affinity for C-terminal fragments of NPY (Wahlestedt et al., 1986; 1990).
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TABLE I
NEUROPEPTIDE Y RECEPTOR SUBTYPES AND THEIR TENTATIVE
PROPERTIES
Y^(76,77)

Y2<76,77)

70 kDa(35,63,64)

50 kDa(35’63-64)

[F^JNPY

Yes(23.53,77)

jsj0(39,53,77)

[L3I,P34]NPY

Yes(1,25'76)

No(25’76)

NPY, 3-36

j^0(1,25,61,76)

Yes(25,61,76,77)

NPY, 8-36

No(1,23)

Yes(4l,47,77)

PYY

Yes(23.6l.77)

Yes(61,77)

PP

No(32,37,77)

No09,77*

N o<47,76)

No(39’76)

Molecular Wt.
Agonists

desamido-NPY
Partial agonist
Agonists potency

Antagonistf

NPY, 3-36 (23) , NPY, 8-36 (47)
PYY > NPY > [L31,P34]NPY
> > C-terminal fragments, PP

PYY > NPY > C-terminal fragments
> > [L31,P34]NPY, PP

PYX-1, PYX-2(42,70)
*Benextramine(l4-42-5272)
*He90481(23,46)
NPYI3.36(23>, NPY, 8-36 (47)

*Benextramine(l4-38’42'72)

Yes(76,77)

Yes(76,77)

Cell lines

HEL(23), PC-12(25,6I)
**SK-N-MC(23’76,77)
MC-IXC (SK-N-MC subclone)(6l’62)

SK-N-BE2(76,77), SMS-KAN(25’62)
SMS-MSN(25’6I'62), CHP-234(25,62)

Major tissue
location

- major post-junctional(76)
- frontoparietal cortex(l5,l6)
- rabbit saphenous vein (10,19)

G-protein linked

- major pre-juctional(76)
- rat vas deferens0 9,28-75)
- porcine hippocampal membrane(1516)

* non-selective antagonist; ** harbors (3<45), (/73) and possibly Y2(35) receptors;
t useful antagonists not available
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receptor consists of 384 amino acids. Analyses of the cDNA sequences confirm that
the receptor is coupled to G-protein. In the region spanning the transmembrane
domains, it shows 29% sequence homology with tachykinin receptors.

Y2 Receptor

As mentioned above, the Y2 receptor is activated not only by NPY and PYY, but
also by their N-terminally truncated variants. Recently, PYY3.36 is suggested to be a
potential selective Y2 ligand (Dumont et al., 1993b). Peptide fragments have been
detected endogenously, but their physiological significance has not been determined
(Wahlestedt et al., 1990). The majority of NPY receptors in the central nervous
system is probably of the Y2 subtype, especially with high densities seen in the
hippocampal formation (Dumont et al., 1990; 1993a).

In the peripheral nerves, the Y2 receptor is predominantly pre-junctional,
suppressing the release of norepinephrine. A prototypical Y2 bioassay is the inhibition
of the electrically-stimulated twitch response in rat vas deferens (Dumont et al.,
1993c; Wahlestedt et al., 1986; Grundemar et al., 1992). Like the Yj receptor, there
are several human neuroblastoma cell lines that harbor Y2 receptors, including
SMS-MSN, SMS-KAN, CHP-234 (Sheikh et al., 1989b) and SK-N-BE2 (Wahlestedt
et al., 1992). Some of these cell lines have been utilized as in vitro models for Y2
agonist assays (Wahlestedt et al., 1992; Inui et al., 1992).
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Studies of solubilized Y2 receptor (rat hippocampus and rabbit kidney membranes)
show that the receptor is a glycoprotein with a molecular weight of 50 kDa (Sheikh &
Williams, 1990a; 1990b; Inui et al., 1992). Y2 is proposed to interact mainly with
the C-terminus of the NPY (Dumont et al., 1993c; Grundemar et al., 1992). The Y2
receptor is less stringent than the Y: receptor in its requirements for the N-terminus
but more stringent in its requirements for the C-terminus (Martel et al., 1990). It
demands an intact amidated C-terminal 25-36.

A G-protein-coupled NPY receptor, which initially thought to correspond possibly
to the Y2 receptor, has been cloned from Drosophila melanogaster (Li et al., 1992).
However, it shows only 23 % sequence homology in the transmembrane regions with
the human Y] receptor (Larhammar et al., 1992). The Drosophila NPY receptor is
now considered not likely to correspond to any of the mammalian NPY/PYY receptor
subtypes. Ligand binding studies reveal that the Y2 receptor belongs to the G-proteincoupled receptor superfamily (Wahlestedt et al., 1992). Benextramine, which blocks
Yj receptor, can also irreversibly block NPY binding to the Y2 receptor (Li et al.,
1991).

Y3 Receptor

In the Y, and Y2 receptors, PYY produces similar effects of NPY in most model
systems with similar or slightly greater potency. In some tissues, however, PYY does
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et al., 1993). Sequence analysis reveals that the bovine locus coeruleus receptor
belongs to the G-protein coupled receptor family, but has only 21 % sequence
homology with the human Y1 receptor in the transmembrane domains (Larhammar
et al., 1992). Ligand binding study supports that the Y3 receptor is linked to pertussis
toxin-sensitive G-protein (Wahlestedt et al., 1992). Y3 may interact with the
cholinergic system since the NPY-induced contraction of the rat distal colon can be
blocked by atropine (Dumont et al., 1993c; Cadieux et al., 1990).

Interactions with Sigma (a) Receptor

The term a receptor was first recommended in 1987 to describe the receptor with
affinity for SKF-10047 (N-allynormetazocine), but not accessible to etorphine, and
with extremely poor affinity for the well-known opioid antagonists, naloxone and
naltrexone (Quirion et al., 1987; for review, Su, 1991; 1993). NPY and PYY were
reported to bind with strong affinities to the rat brain a binding sites (Roman et al.,
1989; 1990). However, others failed to reproduce the results using the same
technique (Tam & Mitchell, 1991). Whether a receptor is an NPY receptor subtype
is still being debated. Despite the controversy, in vivo studies provide more evidence
for the interaction of NPY and a receptors.

In an in vivo binding study, NPY, PYY and [Leu31,Pro34]NPY (a Y, and Y3
agonist) could displace up to 35% of the specific binding of [3H](+)-SKF-10047 to
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a receptors in the mouse hippocampal formation (Bouchard et al., 1993). In a
bioassay using N-methyl-D-aspartate (NMDA)-induced activation of rat CA3 dorsal
hippocampus pyramidal neurons as a model, NPY, [Leu31,Pro34]NPY and NPY 13-36
were active in enhancing NMDA-induced activation dose-dependently. While PYY
and NPY 18-36 did not modify the NMDA responses by themselves, they antagonized
the potentiating effect of NPY (Monnet et al., 1992b). Additionally, the desamidoNPY reduced the neuronal response to NMDA and acted as an inverse agonist
(Monnet et al., 1992b). Two <r receptor antagonists, haloperidol and
a-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-l-piperazine butanol, reversed the
potentiation of the NMDA response induced by NPY, [Leu31,Pro34]NPY or NPY 13-36
and blocked the suppressant effect of desamido-NPY on the NMDA response (Monnet
et al., 1992a). In another bioassay using duodenal alkaline secretion in the rat as a
model, NPY induced a dose-related increase in bicarbonate secretion, which could be
inhibited by a antagonists (Pascaud et al., 1993).

There are subtypes of a receptors (Bowen et al., 1989; Quirion et al., 1992).
NPY is not likely to interact with all of the a receptor subtypes, as it appears to
discriminate between a sites labeled preferentially with (-I-)-[3H]SKF-10,047 and those
labeled with [3H]DTG (Bouchard et al., 1993; Roman et al., 1991). At least one of
the a receptor subtypes is G-protein linked (Beart et al., 1989; Connick et al., 1992).
Using photoaffinity labeling technique, a polypeptide of about 26 kDa has been
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affinity in different cell lines may be, in part, due to the presence of multiple receptor
subtypes.

In studying the long lasting hypotensive effect of NPY, it was shown that some of
the physiological effects of NPY could be blocked by histamine antagonists. This led
to the study of the capability of NPY on releasing histamine from mast cells. NPY
and its various fragments were found to have this ability. It has been argued that
non-receptor mediated effects due to the amphiphilic a-helical region of NPY may be
responsible for activating the G-proteins in mast cells (Grundemar & Hakanson,
1991).

We have recently demonstrated that NPY could modulate the oxidative burst
response in human neutrophils (Wan & Lau, 1994). PYY produced similar effects
while [Leu31,Pro34]NPY and NPY 13-36 induced similar or higher effects. Moreover,
the modulation by NPY was not blocked by benextramine (a non-selective antagonist)
or PYX-2 (a Y, antagonist). These data suggest that neutrophils may have receptors
that are different from the ones discussed above.

Interaction of NPY Receptors with Other Receptors

NPY receptor has been shown to interact with other receptors of the nervous
system. NPY and c^-adrenoceptors can interact through G-proteins (Harada et al.,
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1992; Von Euler et al., 1989) and the interaction is likely to be reciprocal (Harfstrand
et al., 1989). Interaction with ^-adrenoceptor has also been demonstrated in
SK-N-MC human neuroblastoma cell line (Michel et al., 1992). The interaction is
time and concentration dependent and is not mediated via G-protein. In rat
pinealocytes, NPY interacts with a2- and /3-adrenergic as well as VIP receptors,
probably via a G-protein (Harada et al., 1992). NPY receptor also interacts with
cholinergic receptors in certain system (Cadieux et al., 1990).

Signal Transduction Pathways

Y,, Y2 and Y3 receptors have been shown to be coupled to G-proteins (Wahlestedt
et al., 1992). In all the model systems with either Y! (Aakerlund et al., 1990; Michel
et al., 1990; Shigeri & Fujimoto, 1992), Y2 (Wahlestedt et al., 1990) or Y3
(Balasubramaniam & Sheriff, 1990), pertussis toxin-sensitive inhibition of adenylate
cyclase by NPY has been demonstrated. In many cell types, activation of NPY
receptors alters free intracellular Ca2+ concentrations (Aakerlund er al., 1990; Shigeri
& Fujimoto, 1992; Daniels et al., 1989; Motulsky & Michel, 1988). Generation of
inositol phosphates has been demonstrated to associate with the increase in Ca2+ in
some studies (Daniels et al., 1989) but not in others (Motulsky & Michel, 1988).
Thus, NPY receptors may couple to mobilization of Ca2+ from intracellular stores via
inositol phosphate dependent or independent pathways. At present it is not possible to
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ABSTRACT

A micro-fluorometric method for phagocytosis study has been developed using
fluorescein conjugated Escherichia coli K-12 particles. This technique is based on the
uptake of fluorescent particles and quenching of extracellular fluorescence at the end
of the assay. A murine macrophage cell line, J774, was used as a phagocyte model.
The cells were harvested from tissue culture flasks and adjusted to 1 x 106 cells per
ml. They were then dispensed into a 96-well tissue culture plate, 100 fxl per well,
and incubated at 37°C in 5% C02 for 1 h to allow cells to adhere to the bottom of the
wells. The culture medium was aspirated and 100 ^1 of fluorescent E. coli particles
suspended in Hanks’ buffer were added. The plates were further incubated for
various time periods. Buffer solution in the wells was removed by aspiration.
Extracellular fluorescence was then quenched by adding 100 /xl of trypan blue
(250 />tg/ml, pH 4.4). The dye was removed after one minute. The intensity of
fluorescence associated with intracellular fluorescent particles was measured directly
in the wells using a computerized microplate fluorometer at 485 nm excitation and
530 nm emission. This assay provided a rapid and objective measurement of
phagocytosis activity. Using a cultured cell line and a 96-well microtiter plate
format, this assay can facilitate the screening of a large number of various biological
and pharmacological substances for their modulating effects on phagocytosis.

46
Cell line

A murine macrophage cell line, J774A. 1, was obtained from the American Type
Culture Collection (ATCC, Rockville, MD). This cell line has been described as a
reticulum cell sarcoma by Ralph et al. (1975; 1976; 1977) and used as a model for
oxidative burst studies (Lau et al., 1989; 1990; Wan et al., 1992). It has also been
shown to be capable of phagocytosis. J774 cells were grown in DMEM supplemented
with 7.5% heat-inactivated FBS, penicillin (500 U/ml) and streptomycin (5 mg/ml).
The cells were cultured at 37°C in a humidified 5% C02 atmosphere for 3-4 days
before being used for experiments. The viability of cells used in experiments was
always greater than 95 % as determined by trypan blue exclusion.

Phagocytosis assay

Assays were performed using flat-bottom 96-well tissue culture plates (Coming,
Los Angeles, CA). All the incubations were done in a humidified 37°C and 5% C02
incubator. Cells were harvested and resuspended in DMEM supplemented with 7.5%
FBS. Cell concentration was adjusted to 1 x 106/ml, unless otherwise stated, and
100 /d of cell suspension was pipetted into each well. The modulating substance was
added at this time. The plate was incubated for 1 h to allow cells to adhere to the
bottom of the wells. Then the culture medium was aspirated. The E. coli suspension
prewarmed to room temperature was briefly sonicated to disperse any aggregates and
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100 fil were added to each well. For the time course studies the fluorescent particles
were added at different intervals. The plate was covered and incubated for various
time periods. After incubation, the buffer in the plate was removed by aspiration.
Extracellular fluorescence was quenched by adding 100 jd of trypan blue (250 ^g/ml,
pH 4.4). Wells containing only fluorescent particles were used as controls to indicate
complete quenching. After one minute, the dye was removed. The fluorescence
intensity (relative fluorescence unit, RFU) was determined at 485 + 10 nm excitation
and 530 ± 12.5 nm emission wavelengths using an automated fluorescence microplate
reader (Microplate fluorometer Model 7620, Cambridge Technology Inc., Watertown,
M.A.) interfaced with a PC-compatible computer. Captured data were transferred to
statistics and graphics programs directly for analyses without re-entering.

Statistical Analyses

Data were expressed as the mean + SD. For multiple group comparisons, one
way analysis of variance (ANOVA) was employed followed by Tukey’s multiple
range test for honestly significant difference (HSD). ANOVA was performed with
Statgraphics version 5 (STSC, Inc., Rockville, MD). Linear regression analyses and
graphics were performed with SigmaPlot version 4.1 (Jandel Scientific, Corte
Madera, CA). Statistical significance was defined as p < 0.05.

48
RESULTS

The fluorescent labelling of the commercial E. coli particles was found to be
homogeneous when assessed by fluorescence microscopy. Figure 1 shows that the
intensity of fluorescence (RFU) was directly proportional to the concentration of
fluorescein conjugated E. coli over a wide range of 5.86 x 105 to 2.4 x 109 particles
(r = 0.997). The particles were serially diluted with pH 4.4 buffer to correspond
with the pH inside the phagosomes of macrophages (Sahlin et al., 1983).

The concentration of trypan blue required to completely quench extracellular
fluorescence was determined by exposing 3 or 6 x 108 particles per well to serial
dilutions of the dye in a 96-well filtration plate (Millipore, Bedford, MA). Complete
quenching of the fluorescence was obtained with 250 fig/ml of the dye (Figure 2).

The fluorescence values of the edge wells of a 96-well plate were generally lower
by as much as 22% when compared with the mean values of the center wells, due to
the so-called "edge effect". In our experiments, the edge wells were not used. They
were filled with HBSS or distilled water to maintain moisture in the plate during
incubation.

Experiments were performed to estimate the optimal cell concentration for the
phagocytosis assay. Various concentrations of phagocytes were exposed to a fixed
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Figure 1. Relationship between the concentration of fluorescein conjugated E. coli
particles and the intensity of fluorescence (RFU). Fluorescent bacteria were diluted
serially in pH 4.4 buffer and RFU’s were determined. Each point represents the
mean ± SD of triplicate samples. The small error bars are masked by symbols.
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Figure 2. Quenching of fluorescence by trypan blue. E. coli particles, 3 or 6 x 108
per well, were pipetted into a 96-well filtration plate. Buffer was removed by
vacuuming through a vacuum-manifold. They were then exposed to serial dilutions of
trypan blue at pH 4.4. Controls consisted of wells containing fluorescent E. coli
without trypan blue. Each point depicts the mean of triplicate determinations.
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number of bacteria. Wells containing 1 x 105 J774 cells provided the strongest
signals (Figure 3). This concentration of J774 cells was used in the subsequent
experiments. A slight decrease in signals, though statistically not significant, was
observed with cell concentrations higher than 1 x 105 per well.

Figure 4 shows a linear relationship between the extent of phagocytosis and the
increase in bacterial concentration up to 3 x 108 particles per well (r = 0.999). The
uptake of bacteria approached saturation at 6 x 108 bacteria per well. Figure 5
illustrates the uptake of fluorescein conjugated E. coli by J774 cells over a period of
4 h. A steady increase in signals over time was observed.

Figure 6 demonstrates the effect of cytochalasin D, a known phagocytosis
inhibitor (Parod & Brain, 1986), on the activity of J774 cells. The cells were
preincubated with cytochalasin D for 1 h. The modulating substance was then
removed. Bacteria were added and the plates were further incubated for 2 h. A
dose-dependent inhibition was observed. The plates were examined with an inverted
microscope. The reduction in phagocytosis was not due to a decrease in cell
adherence or viability. Phagocytosis was not significantly affected by 0.09% DMSO,
solvent for cytochalasin D, when compared with the control containing HBSS.

Table I presents the data from four experiments. The SD values derived from
replicate samples were low and the coefficients of variation (CV) ranged from 0.01 %
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Figure 3. Estimation of optimal cell concentration for phagocytosis assay.
Macrophages were serially diluted in a 96-well plate. Bacteria, 3 x 108 in 100 /xl,
were added to each of the wells and the plate was incubated for 2 h. Each point is
the mean ± SD of six samples.
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Figure 4. Extent of phagocytosis with increasing concentration of bacteria.
Macrophages were incubated with various concentrations of E. coli for 2 h. Each
point represents the mean + SD of six replicates. Asterisk denotes statistically
significant difference from the control wells, which contained cells only (p < 0.05).
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Figure 5. Time course of uptake of fluorescein conjugated E. coli particles. J774
cells were incubated with four concentrations of E. coli. Each point is the
mean ± SD of triplicate determinations. All points are statistically different from the
controls (at time zero) except those indicated with an asterisk (p < 0.05).
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Figure 6. Inhibition of uptake of fluorescein conjugated E. coli by cytochalasin D.
Different concentrations of cytochalasin D were preincubated with macrophages at
37°C for 60 min and then discarded. E. coli, 3 x 108 in 100 /xl, was then added to
each well and the plate was further incubated for 2 h. Control consisted of cells
without exposure to cytochalasin D. Each point is the mean ± SD of six
measurements. All points are statistically different from the control (p < 0.05).
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TABLE I
REPRODUCIBILITY OF THE PHAGOCYTOSIS ASSAY.
Data from four randomly selected experiments are presented here. In all experiments,
1 x 105 J774 cells per well were plated. Cells in Exp. 1 & 2 and 3 & 4 were exposed
to 3 and 0.75 x 108 bacteria, respectively. Each number represents the mean ± SD
of triplicate samples. Coefficients of variation [CV = (SD/mean) x 100%] are shown
in brackets.

Time of
Incubation

Relative Fluorescence Unit
Exp. 1

Exp. 2

Exp. 3

Exp. 4

15 min

126.00 ± 2.00
(1.59)

128.33 ± 3.51
(2.74)

66.00 ± 3.46
(5.24)

68.00 ± 1.00
(1.47)

30 min

196.00 ± 8.72
(4.45)

206.33 ± 14.36
(6.96)

88.33 ± 8.96
(10.14)

90.33 ± 9.07
(10.04)

60 min

296.67 ± 6.03
(2.03)

290.33 ± 8.08
(2.78)

122.67 ± 10.21
(8.32)

131.00 ± 8.19
(6.25)

120 min

478.67 ± 19.43
(4.06)

442.00 ± 21.79
(4.93)

174.00 ± 8.66
(4.98)

188.00 ± 12.49
(6.64)

180 min

667.00 ± 10.82
(1.62)

603.67 ± 13.32
(2.21)

219.67 ± 8.08
(3.68)

241.33 ± 1.15
(0.01)
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to 10.14% with an average of 4.507 + 2.867%, indicating a high degree of
reproducibility of this technique.
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DISCUSSION

We have described a simple and rapid assay for studying phagocytosis. The
technique is objective and reproducible. The micro-fluorometric method offers
several important advantages. Since this assay utilizes 96-well plates, a bulk of
samples can be processed in parallel within five minutes after the completion of
incubation. Non-specific signals of bacteria adhering to the surface of macrophages
are eliminated by fluorescence quenching. Readings are taken from the same wells
used for incubation, thus eliminating the need of transfer to other vessels. This
procedure results in no biohazard wastes. Compared with other photometric methods,
this assay requires approximately only one tenth the amount of cells. It is neither
labor intensive nor highly technical.

As in any other assays for testing factors affecting phagocytic functions, the cell
viability and adherence should be checked to assure that the results are not affected by
these two parameters. This can be easily accomplished by examining the 96-well
plate with an inverted microscope.

A cultured cell line, J774, was used as a model in the development of this assay.
We also tested isolated neutrophils with this assay and obtained a linear relationship
between phagocytosis and bacterial concentration. It is likely that this assay can be
adapted for various kinds of phagocytes. For testing the effect on phagocytosis by
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substances that are known to affect cell adherence, 96-well filtration plates can be
employed.

Fluorescein conjugated E. coli K-12 bio-particles used in the development of this
assay and other fluorescent bio-particles, such as Staphylococcus aureus and
Saccharomyces cerevisiae, are commercially available. Fluorescent bio-particles can
also be prepared in the laboratory using other microorganisms (Drevets & Campbell,
1991; Oben & Foreman, 1988; Sjursen et al., 1989).

The microplate fluorescence reader used in this study has many other applications
such as measurements of lymphocyte proliferation (Bialek and Abken, 1991),
cytotoxicity assays (Brenan and Parish, 1988; Kolber et al., 1988; Essig-Marcello and
van Buskirk, 1990;), enzyme-linked immunosorbant assays and oxidative burst
activities (Wan et al., 1992). Instruments similar to the Microplate Fluorometer
Model 7620 used in this study are available from several manufacturers, such as FCA
(Idexx Laboratories, Inc., Westbrook, ME), Fluoroskan II (Labsystems, Raleigh, NC)
and CytoFluor 2300 (Millipore, Bedford, MA). We have evaluated these instruments
and found them to be suitable for micro-fluorometric determinations.

In conclusion we have developed a phagocytosis procedure that does not require
extensive preparation or manipulation. A macrophage cell line, J774, was used as a
source of phagocytes and fluorescein conjugated E. coli particles were purchased
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commercially. The 96-well microtiter plate format permits easy testing of a large
number of samples and screening of phagocytosis modulating substances.
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ABSTRACT

A micro-fluorometric assay using 2,,7,-dichlorofluorescin diacetate (DCFH-DA)
to monitor oxidative burst (OB) in phagocytes has been developed. This assay is
based on the oxidation of nonfluorescent DCFH-DA to highly fluorescent
2’,7’-dichlorofluorescein (DCF) both intracellularly and extracellularly. A murine
macrophage cell line, J774, and a human monocytic cell line, Mono Mac 6, were
used as models. The cells were harvested from tissue culture flasks, washed, counted
and adjusted to desired concentrations. They were then dispensed into a 96-well flatbottom tissue culture plate. After adding DCFH-DA and an agent eliciting OB, the
plates were incubated in 5% C02 at 37°C for various times. The intensity of
fluorescence was measured directly in the wells of the tissue culture plate with the
cells in situ using a computerized microplate fluorometer at 485 nm excitation and
530 nm emission. This assay provided a rapid measurement of oxidative burst of
phagocytes. The automated micro-fluorometric assay may be suitable for screening
the immunomodulating activity of various biological and pharmacological substances.
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INTRODUCTION

Phagocytes, such as neutrophils and macrophages, undergo an oxidative burst in
response to phagocytic or membrane stimuli, with generation and release of a variety
of reactive oxygen metabolites. This coordinated sequence of biochemical reactions is
marked by a rapid oxygen uptake followed by the one-electron reduction of oxygen to
superoxide anion (02) using NADPH or NADH as the electron donor and catalyzed
by a NAD(P)H oxidase (Babior, 1978; 1979; Johnston, 1978). 02" is subsequently
converted to hydrogen peroxide (H202) by either spontaneous or enzyme-mediated
dismutation.

The generation of reactive oxygen species by the process of oxidative burst is
considered a major mechanism by which phagocytes mediate their antimicrobial and
tumoricidal functions (Babior, 1978; 1979; Murray and Cohn, 1980). Many
substances, generally called triggering agents, are able to induce the sequence of
reactions while other substances, called modulating agents, can modify the magnitude
of the response. Modulating agents include a variety of biological and
pharmacological substances, such as lipopolysaccharide (Johnson and Sung, 1987;
Aida and Pabst, 1991), Corynebacterium parvum (Tosk et al., 1989), and a number of
antibiotics (Nielsen, 1989; Hansbrough et al., 1991; Krause et al., 1991;). Some
modulating agents have been employed to augment the immune system against cancer
cells (Lau et al., 1989; 1990; Tosk et al., 1989, Rittenhouse et al., 1991). Factor
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Xin of blood coagulation has been suggested as a physiological suppressive agent for
oxidative burst (Stief, 1991).

The oxidative burst can be monitored by assays of oxygen consumption, hexose
monophosphate shunt activity, chemiluminescence (Allen et al., 1972; Allen, 1982),
generation of reactive oxygen derivatives (hydrogen peroxide, superoxide, hydroxyl
radicals), or formation of redox reaction products (e.g. protein iodination, tetrazolium
dye reduction) (Segal, 1974; Oez et al., 1990). However, these assays, in general,
require a large number of cells and are not suitable for handling a large quantity of
samples.

We now describe a simple, rapid assay for the measurement of oxidative burst,
using 2,,7’-dichlorofluorescin diacetate (DCFH-DA). DCFH-DA is a membrane
permeant diacetate derivative of 2’,7’-dichlorofluorescin (DCFH). Upon entering the
cells, the diacetate group is cleaved off enzymatically. Both DCFH-DA and DCFH
are nonfluorescent fluorescein analogues. They are oxidized to highly fluorescent
2,,7,-dichlorofluorescein (DCF) by phagocytes during oxidative burst, mainly by
H2O2 (Bass et al., 1983). With DCFH-DA as the fluorescent probe intracellular and
extracellular reactive oxygen metabolites can be detected. Using cultured cell lines
and 96-well microtiter plate format, this assay facilitates the screening of a large
number of samples for their immunomodulating effects on the oxidative burst in
phagocytes.
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MATERIALS AND METHODS

Reagents

Phorbol myristate acetate (PMA), zymosan A, N,N’-dimethyl formamide (DMF),
dimethyl sulfoxide (DMSO) and Hank’s balanced salt solution (HBSS) were all
obtained from Sigma Chemicals (St. Louis, MO). 2,,7’-dichlorofluorescin diacetate
(DCFH-DA) was purchased from Molecular Probes (Eugene, OR). Dulbecco’s
modified Eagle’s medium (DMEM) and RPMI 1640 were from GIBCO (Grand
Island, NY). Fetal bovine serum (FBS) was supplied by HyClone Laboratories
(Logan, UT).

PMA was dissolved in DMSO at a concentration of 1 mg/ml and stored at -20°C.
Stock solution of DCFH-DA was prepared in DMF at a concentration of 10 mM and
stored in the dark in nitrogen at -20°C. DCFH-DA was stable for at least six months
under these conditions. Both PMA and DCFH-DA were diluted one hundred fold in
HBSS just before use. Zymosan was suspended in HBSS at concentrations of 10 and
50 mg/ml and stored at 4°C.
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Cell lines

The murine macrophage cell line, J774A. 1, was obtained from the American
Type Culture Collection (ATCC) (Rockville, MD). This cell line has been described
as a reticulum cell sarcoma by Ralph et al. (1975; 1976; 1977) and used as a model
for oxidative burst study (Tosk et al., 1989). J774 cells were grown in DMEM
supplemented with 10% heat-inactivated FBS, penicillin (500 U/ml) and streptomycin
(5 mg/ml).

The human monocytic cell line. Mono Mac 6, was kindly provided by Dr. H.W.
Loms Ziegler-Heitbrock, University of Munich, Munich, FRG. This cell line
constitutively expresses phenotypic and functional features of mature monocytes
(Ziegler-Heitbrock et al., 1988). Mono Mac 6 cells were grown in RPMI 1640
supplemented with 10% heat-inactivated FBS, penicillin (500 U/ml) and streptomycin
(5 mg/ml). Both J774 and Mono Mac 6 are known to be capable of oxidative burst.
J774 is a "high responder" while Mono Mac 6 a "low responder" as shown by the
chemiluminescence method in our laboratory.

The cells were cultured at 37°C in a humidified 5% C02 atmosphere for 3-4 days
before being used for experiments. The viability of cells used in experiments was
always >90% as determined by trypan blue exclusion.
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Oxidative burst assay

Cells were harvested, washed once and resuspended in HBSS. Assays were
performed using 96-well tissue culture plates. Except in experiments for determining
the optimal cell concentration, the cell density was adjusted to 2 x lOVml and 100 /d
of the cell suspension was pipetted into each well. A triggering agent, zymosan or
PMA, and DCFH-DA diluted in HBSS were added to each well. The plate was
covered with a lid and incubated for various time intervals in a 37° C humidified
incubator gassed with 95% air and 5% C02. The fluorescence intensity (relative
fluorescence unit, RFU) was determined at 485 nm excitation and 530 nm emission
wavelengths using an automated fluorescence reader (Microplate Fluorometer Model
7610; Cambridge Technology Inc., Watertown, MA) interfaced with a PC-compatible
computer. Captured data were transferred to statistics and graphics programs directly
for analysis without re-entering. To prevent dispersion of light when the fluorometric
readings were made, flat bottom plates (Coming, Los Angeles, CA) were used.
Since the cells in the plates were not disturbed by the measuring procedure, the plates
could be incubated for additional time periods and re-read as desired.

Statistical Analysis

Data were expressed as the mean + SEM. For multiple group comparisons, one
way analysis of variance (ANOVA) was employed followed by Tukey’s multiple
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range test for honestly significant difference (HSD). Statistical significance was
defined as p < 0.05. Statistical procedures were performed with Statgraphics version
5 (STSC, Inc., Rockville, MD) and graphical analyses were performed with
SigmaPlot version 4.1 (Jandel Scientific, Corte Madera, CA).
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RESULTS

It was noted that the fluorescence values of the edge wells of the 96-well plate
were generally higher, the so-called "edge effect". In our experiments, the edge
wells were not used. They were filled with HESS or distilled water to maintain
moisture in the plate during incubation. For the convenience of data transfer to
another computer program for analysis, the experiment layout followed a certain
format, i.e., triplicates in vertical columns.

Table I shows the data from five experiments. The SEM values derived from
replicate samples were low and the coefficients of variation (CV) ranged from 0.08%
to 5 %. When the same wells were read repeatedly at 1 min intervals, the variations
in readings were minimal (data not shown), showing that the microplate fluorescence
reader was capable of yielding a high degree of reproducibility.

In experiments to determine the optimal cell concentration for OB, cells were
diluted serially in a 96-well tissue culture plate and OB was triggered with 100 fxg of
zymosan (Figure 1). A significant response in J774 cells could be detected at a cell
concentration as low as 3.5 x lOVwell. The signal reached a peak at a cell
concentration of 2.3 x lOVwell and then declined, probably due to fluorescence auto
quenching or quenching by the cells. Table II shows the results of J774 cells
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TABLE I
OXIDATIVE BURST BY CELL LINES MEASURED WITH MICROPLATE
FLUOROMETER.
Data from five randomly selected experiments are presented here. In experiments
1-3, J774 cells were used. In experiments 4 and 5, Mono Mac 6 cells were used. In
all experiments, 2 x 104 cells per well were plated. Replicate samples were read after
60 min of incubation with zymosan and DCFH-DA (10 juM/well). Numbers in
brackets represent the numbers of replicates. (CV = coefficient of variation)
Relative Fluorescence Unit (RFU)
Stimulants

Exp. 1 (8)

Exp. 2 (8)

Exp. 3 (6)

Exp. 4(6)

Exp.5(3)

no stimulant
mean + SEM
CV (%)

51.0 ± 0.25
0.49

32.9 ± 1.01
3.16

61.5 ± 1.22
1.98

77.3 ± 2.49
3.22

61.4 + 3.06
4.98

zymosan A (20 /xg)
mean + SEM
CV (%)

81.0 ± 1.54
1.90

53.0 ± 0.81
1.53

186.8 ± 7.87
4.21

86.4 ± 2.12
2.45

73.7 ± 2.66
3.61

zymosan A (500 fig)
mean + SEM
CV (%)

459.2 ± 10.4
2.26

307.1 ± 2.43

525.0 + 8.59
1.64

211.7 + 3.61
1.71

201.4 ± 7.19
3.57

0.08
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TABLE II
RELATIONSHIP BETWEEN CELL NUMBER AND FLUORESCENCE
INTENSITY.
J774 cells were diluted serially in a 96-well tissue culture plate and incubated with
250 ng of PMA and 10 /xM of DCFH-DA. After 1 h of incubation the fluorescence
readings were taken.

Relative fluorescence unit (RFU)

Number of cells
per well

stimulated cells
(250 ng PMA)

unstimulated
cells

stimulated/
unstimulated
cells RFU ratio

Exp. (1)
1.80
3.59
7.19
1.44
2.88
5.75
1.15
2.30
4.60

x
x
x
x
x
x
x
x
x

103
103
103
104
104
104
105
105
105

7.9
10.9
15.9
25.9
51.0
77.8
119.4
144.5
193.8

±
±
±
±
±
±
±
±
+

0.38
0.62
0.29
2.43
0.62
6.30
6.94
16.99
5.99

7.3
8.8
10.3
13.2
22.1
31.0
49.5
77.5
126.2

±
±
±
±
±
±
±
±
±

0.52
0.26
0.15
0.62
1.06
0.67
1.79
4.60
6.96

1.082
1.237
1.544
1.962
2.308
2.439
2.412
1.864
1.537

9.3
12.2
17.5
25.7
44.0
76.4
113.3
160.1
175.3

+ 0.72
± 0.56
± 0.84
± 1.65
± 1.55
± 4.74
± 8.76
±10.95
±11.30

8.6
9.2
12.1
16.1
21.7
33.7
47.3
73.9
121.7

±
±
±
±
±
±
±
±
±

0.21
0.22
0.49
0.49
0.12
0.26
2.57
3.03
0.74

1.081
1.326
1.446
1.596
2.028
2.267
2.395
2.166
1.440

Exp. (2)
1.80
3.59
7.19
1.44
2.88
5.75
1.15
2.30
4.60

x
x
x
x
x
x
x
x
x

103
103
103
104
104
104
105
105
105

82

Figure 1. Relationship between cell number and fluorescence intensity. J774 cells
were diluted serially in a 96-well tissue culture plate and incubated with 100

of

zymosan and 1 fxM of DCFH-DA. The fluorescence readings were taken after 1 h of
incubation at 37°C. All points depicting stimulated cells are significantly different
from unstimulated cells (p<0.05).
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TABLE HI
OXIDATIVE BURST KINETICS STUDY OF J774 CELLS STIMULATED WITH
PMA OR ZYMOSAN.
Cells were stimulated and readings were taken at 1, 2 and 3 h. Experiments were set
up in triplicate and 10 /xM/well of DCFH-DA was used. The results represent the
calculated means ± SEM derived from individual wells. The numbers in brackets
represent the values after blanks (wells containing unstimulated cells) were subtracted.

Stimulant
(amount/well)

Relative Fluorescence Unit (RFU) at
1 h

2h

3 h

no stimulant

103.9 ± 0.48

155.1 ± 1.78

210.0 ± 2.33

PMA (62.5 ng)

240.8 ± 3.16
(136.9)

388.1 ± 5.09
(233.0)

509.9 ± 6.30
(299.0)

PMA (250 ng)

308.5 ± 1.96
(204.0)

417.2 ± 6.47
(262.1)

500.1 ± 8.43
(290.1)

zymosan (31.25 /zg)

508.3 ± 40.8
(389.3)

774.8 ± 29.1
(611.0)

1043.0 ± 30.95
(883.4)

zymosan (125 /zg)

1056.7 ± 4.33
(946.7)

1437.3 ± 14.24
(1273.6)

1907.7 + 24.13
(1698.1)
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triggered with 250 ng of PMA. The OB response was minimal. The signal-tobackground ratio reached a peak at cell concentrations between 0.2 - 2 x 105 per well,
further increase in cell number led to a decline in the ratio.

Experiments were carried out with J774 cells using two different concentrations of
fluorescence probe, 1 /xM (Figure 2a) and 10 juM (Figure 2b). Both concentrations
gave essentially similar dose-response curves. A ten-fold increase in the
concentration of DCFH-DA increased the magnitude of the responses proportionally.
When J774 cells were triggered with 250 ng of PMA, however, responses were
detected with 10 /xM of the fluorescence dye but not with 1 /xM (data not shown). In
most of the experiments in this study 10 fiM of DCFH-DA was used.

Both Mono Mac 6 cells (Figure 3a) and J774 cells (Figure 3b) showed good doseresponse relationships with zymosan. Mono Mac 6 cells exhibited a much lower
magnitude of response than J774 cells. This corresponds to results obtained from
chemiluminescence assays (unpublished data) showing that Mono Mac 6 is a "low
responder" compared to J774.

Since the cells in the plates were not disturbed by the measuring procedure, the
plates could be incubated for additional time periods and re-read. Fluorescence
photobleaching of DCF under this conditions was negligible. Dose-response and
kinetic studies were carried out simultaneously with J774 cells. Cells were stimulated
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Figure 2. Effect of two concentrations of fluorescence probe on OB. (a) 1 ^M/well and (b) 10 juM/well of DCFH-DA. J774
cells were incubated with different concentrations of zymosan and DCFH-DA at 37°C for 1 h and fluorescence readings were
then taken. Each data point represents triplicate samples.
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Figure 3. OB dose response of two cell lines to zymosan, (a) Mono Mac 6 cells
(b) J774 cells. Cells were incubated with different concentrations of zymosan and
10 /xM of DCFH-DA at 37°C for 1 h and fluorescence readings were then taken.
Each data point represents triplicate samples.
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with serial dilutions of PMA, ranging from 1000 to 7.81 ng, and zymosan, ranging
from 500 to to 3.9 /xg. Table IQ shows the results with two concentrations from the
linear portions of the dose-response curves of these agents. With 250 ng of PMA, the
oxidative response was most intense during the first hour of incubation. In the course
of the second and third hours, the increases in fluorescence readings were 128% and
142% of the first hour reading respectively. Cells triggered with 62.5 ng of PMA
reached the same peak as those triggered with 250 ng. The oxidative burst response
to zymosan, both 31.25 and 125 fig, showed a linear increase over the time course of
three hours (r=0.998 and 0.997, respectively).
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DISCUSSION

This report describes a simple, rapid automated microassay for measuring
oxidative burst of phagocytes. The assay may be useful for screening biological and
pharmacological agents for their immunomodulating effects on oxidative burst. It
could accommodate the rapid assay of fractions during purification of such substances.

Even though only two cell lines were used in this study, this technique should be
applicable to all other cells capable of oxidative burst. Preliminary data from our
laboratory showed that whole blood from humans or animals could be used in this
assay. In one experiment, human heparinized whole blood was diluted 1 to 512 fold
serially in Hank’ buffer and triggered with 100 /xg of zymosan. Dilutions of whole
blood 32 to 128 fold gave a good signal-to-background ratio, ranging between 21 and
23, while 1 to 16 and 256 to 512 fold dilutions gave signal-to-background ratios of
1.2 to 1.7 and 8 to 12 respectively . This assay may be adapted for the detection of
chronic granulomatous disease and may prove useful in monitoring the immune status
of patients in clinical settings. Since a minute amount of blood is needed, the assay
can also be useful for neonates.

Various investigators have studied oxidative burst products of phagocytes using
flow cytometry (Bass et al., 1983; Szejda et al., 1984; Mandell et al., 1987; Ryan
et al., 1990). While the flow cytometry provides information about individual cells,
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the microplate technique described here offers the following advantages. (1) In the
flow cytometry assay, only the intracellular fluorescence is measured. In the
microplate technique, both intracellular and extracellular products of oxidative burst
are measured. Since the bulk of the reactive oxidative burst product is released into
the extracellular environment, this technique detects a more realistic response. (2)
Large numbers of samples can be tested in parallel quite rapidly, i.e. 60 samples can
be processed in approximately 30 to 45 minutes. (3) The fluorescence reading can
be obtained with cells in situ and can be made repeatedly in the same wells. Since 96
wells are read in about 1 min, there is little interference of 02 release by the
measuring procedure. Kinetic study is thus possible without setting up multiple
samples. (4) A microplate fluorescence reader can be more readily available than a
flow cytometer in a clinical laboratory. A microplate reader is simple to operate and
does not require lengthy specialized training. The adaptation of this assay for clinical
use is more feasible.

Compared with other conventional methods, this method requires relatively small
numbers of cells and small amounts of reagents. However, the minimal number of
cells required for a satisfactory response has to be determined for each cell type or
subpopulation of cells used. For the murine macrophage cell line, J774, the useful
range was from 3.5 x 103 to 2.3 x 105 cells per well. For the human monocytic cell
line, Mono Mac 6, the range was from 1 x 104 to 1.25 x 105 cells per well.
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We have used the chemiluminescence (CL) assay for studying oxidative burst for
a number of years (Lau et al., 1989; 1990; Tosk et al., 1989, Rittenhouse et al.,
1991). We now find this micro-fluorometric assay much more versatile and reliable
compared with CL assay. Although DCFH-DA was used as the probe for oxidative
burst measurements in this study, a variety of fluorogenic substrates may be used.
Other fluorogenic substrates that may be used for oxidative burst assays include the
reduced rhodamine derivative, dihydrorhodamine 123 (Kinsey et al., 1987; Mcllvain
et al., 1988); the reduced xanthene derivative, dihydrotetramethylrosamine (Whitaker
et al., 1989; 1991); and hydroethidine (Kobzik et al., 1990; Rothe and Valet, 1990).

The microplate fluorescence reader required for the technique described in this
paper has other applications such as measurements of lymphocyte proliferation (Bialek
and Abken, 1991), cytotoxicity assays (Brenan and Parish, 1988; Kolber et al., 1988;
Essig-Marcello and van Buskirk, 1990;) and enzyme-linked immunosorbant assays.
Instruments similar to the Microplate Fluorometer Model 7610 used in this study are
available from several manufacturers, such as FCA (Idexx Laboratories, Inc.,
Westbrook, ME), Fluoroskan El (Labsystems, Raleigh, NC), and CytoFluor 2300
(Millipore, Bedford, MA). We have evaluated these instruments and found them to
be suitable for micro-fluorometric determinations.
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ABSTRACT

Sympathetic nerve fibers with neuropeptide Y (NPY) have been found to
innervate immune organs. Plasma levels of NPY were significantly increased in
people under chronic stress. We now report that NPY modulates oxidative burst
(OB) in human neutrophils. Neutrophils were isolated from the whole blood of
healthy volunteers and resuspended in Hanks’ balanced salt solution (HBSS). Cells
were incubated with NPY in a 96-well plate for 4 h. OB was triggered with zymosan
and measured with a micro-fluorometric method using dichlorofluorescin diacetate.
NPY enhanced OB in a time and dose-dependent fashion. The reaction was specific
since non-specific peptides did not produce any significant effects, while anti-NPY
antibody neutralized this enhancement. Peptide YY (a receptor agonist of NPY
and Y2, but not of Y3 or sigma) induced similar responses. [Leu31,Pro34]NPY (a Y
Y3, and sigma agonist) and NPY C-terminal fragment 13-36 (a Y2, Y3, and sigma
agonist) induced similar or higher responses. PYX-2 (a Yj antagonist), benextramine
(a Y! and Y2 as well as a-adrenoceptor antagonist), or haloperidol (a sigma
antagonist) did not block NPY-induced responses. Instead, the effect of NPY was
amplified in the presence of benextramine. Our data suggest that NPY may be a
mediator for regulating immune responses during chronic stress via an atypical
receptor that has yet to be identified. We further hypothesize that NPY may modulate
immune functions in cooperation with catecholamines.
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INTRODUCTION

Stress has long been implicated in immunosuppression (for review, Kiecolt-Glaser
& Glaser, 1991). Even though adrenal glucocorticoids are partly responsible for the
suppressive effect, steroid hormones are not the sole players in neuroendocrine
modulation of the immune system. Studies have shown that stressed adrenalectomized
animals are functionally immunosuppressed (Keller et al., 1983). Plasma levels of
epinephrine and norepinephrine are known to increase in animals under acute stress
(Zukowska-Grojec et al., 1988), and these catecholamines have been shown to
suppress the immune system (Madden & Livnat, 1991). However, a recent study
showed that people under chronic stress had no change in the circulating levels of
these catecholamines while increased plasma levels of neuropeptide Y (NPY) were
documented (Irwin et al., 1991). Furthermore, an inverse correlation of NPY level
and natural killer (NK) activity was demonstrated (Irwin et al., 1991), and
sympathetic nerve fibers with NPY were found to innervate immune organs (Romano
et al., 1991; Weihe & Krekel, 1991). NPY may play an important role in immune
modulation in people under chronic stress.

NPY has only recently been studied in the context of immunomodulatory effects.
In a large survey study examining the effects of a number of neuropeptides, Soder &
Hellstrom (1987) demonstrated that NPY inhibited the spontaneous and mitogen
(PHA)-pulsed proliferative activities of guinea pig lymph node cells. On the other
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hand, NPY did not have any effects on human thymocytes or rat spleen cells (Soder
& Hellstrom, 1987), or mouse spleen cells (Johansson & Sandberg, 1989). In
contrast, Jones et al. (1990) demonstrated inconsistent effects of NPY on the
proliferative responses of human peripheral blood T cells to concanavalin A.
Repeated studies over time suggested that the effects of NPY might be altered by the
physiological state of the cell donor. A recent publication showed that NPY could
induce a suppression in NK activities (Nair et al., 1993).

Polymorphonuclear leukocytes (neutrophils) play a prominent role in the host
response to infectious diseases.

They have also been found to infiltrate tumors

(Dallegri & Ottonello, 1992) and play a role in other pathological inflammatory
reactions such as septic shock, adult respiratory distress syndrome (Gadek, 1992;
Windsor et al., 1993), and rheumatoid arthritis (Kitsis & Weissmann, 1991). A key
initial step of inflammation is adhesion of leukocytes to the endothelium. NPY has
been shown to increase the adhesiveness of endothelial cells for phagocytes such as
neutrophils and monocytes (Sung et al., 1991). One major bactericidal and cytocidal
mechanism used by phagocytes is the production of reactive oxygen species during
oxidative burst (OB). Our study was designed to examine the direct effect of NPY on
OB activities of neutrophils in vitro.
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MATERIALS AND METHODS

Reagents

Neuropeptide Y (NPY, human), [Leu31,Pro34]NPY (human), NPY C-terminal
fragment 13-36 (NPY 13-36? porcine), peptide YY (PYY, human), benextramine,
haloperidol, poly-Ala-poly-Lys (11.6 kDa), poly-Asp-Glu (7 kDa), zymosan A,
N,N’-dimethyl formamide (DMF), phosphate buffered saline (PBS), and Hanks’
balanced salt solution (HBSS) were all obtained from Sigma Chemical (St. Louis,
MO). PYX-2 was from Peninsula Laboratories (Belmont, CA). NPY and PYY were
also obtained from Peninsula Laboratories or BACHEM Bioscience (King of Prussia,
PA). Rabbit anti-NPY antibody was purchased from Accurate Chemical & Scientific
(Westbury, NY). 2’,7’-dichlorofluorescin diacetate (DCFH-DA) was purchased from
Molecular Probes (Eugene, OR). Rosewell Park Memorial Institute (RPMI) 1640
medium was from GEBCO (Grand Island, NY). All peptides were dissolved in HBSS,
aliquoted, and stored at -20°C. Stock solution of DCFH-DA was prepared in DMF
at a concentration of 10 mM and stored in the dark in nitrogen at -20°C. Zymosan
was suspended in HBSS at a concentration of 10 mg/ml and stored at 4°C.

Blood donors

Permission for using human subjects was obtained from Loma Linda University
Institutional Review Board (protocol #93110). Donors were healthy, adult, male
subjects. All donors were apprised of this study and informed consents were obtained
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consistent with the university policies. Subjects were free of medical or psychiatric
illness and were not taking any medications, including nonsteroidal anti-inflammatory
agents and substance of abuse. Their mean age was 27.67 years, ranging between 23
and 42 years.

Leukocyte preparation

Blood from the cubital vein of healthy volunteers was collected in Vacutainer
tubes (Becton Dickinson, Lincoln Park, NJ) with 143 USP units of sodium heparin
per 10 ml of blood. Polymorphonuclear leukocytes were separated from whole blood
by the one step Hypaque-Ficoll method (Ferrante & Thong, 1980). Briefly, 5-7 ml of
whole blood were layered on 4 ml of the Neutrophil Isolation Medium (NIM) (Los
Alamos Diagnostics, Los Alamos, NM), and centrifuged at 400 x g for 40 min at
room temperature. The neutrophils were found in a separate band in the NIM below
the mononuclear cells and above the erythrocytes. The neutrophils were harvested
and washed twice with PBS. After being resuspended in HBSS, their numbers were
adjusted to 1 x 106 cells/ml.

Oxidative burst assay

The assay determining oxidative burst was previously described (Wan et al,
1993). Assays were performed using 96-well tissue culture plates. All incubations
were done in a 37°C humidified incubator with 5% C02. Cell suspension (100 ^1)
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was pipetted into each well. NPY or various analogs were added in different
concentrations. The plate was pre-incubated for 4 h, unless otherwise stated. A
triggering agent, 100 /xg of zymosan, together with 100 /xM DCFH-DA in 10 /xl of
HBSS was added to each well. The plate was covered with a lid and incubated for
60 min. The fluorescence intensity (relative fluorescence unit, RFU) was determined
at 485 ± 10 nm excitation and 530 ± 12.5 nm emission wavelengths using an
automated microplate fluorescence reader (Microplate Fluorometer Model 7620;
Cambridge Technology Inc., Watertown, MA) interfaced with a DOS-compatible
computer. In kinetic studies, RFU was determined at half hour intervals after
triggering OB. Captured data were transferred to statistics and graphics programs
directly for analysis. To prevent dispersion of light when the fluorometric readings
were made, flat bottom plates (Coming, Los Angeles, CA) were used.

Statistical Analyses

Data were expressed as the mean ± SD. For multiple group comparisons,
one-way analysis of variance (ANOVA) was employed. Where ANOVA indicated
differences, Tukey’s multiple range tests for honestly significant difference (HSD)
were performed to specify the differences. ANOVA and multiple range tests were
performed with Statgraphics version 5 (STSC, Inc., Rockville, MD). Graphs were
prepared with SigmaPlot version 4.1 (Jandel Scientific, Corte Madera, CA).
Statistical significance was defined as /? < 0.05.
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RESULTS

It was observed that the basal levels of OB of neutrophils (untreated controls of
more than 50 various experiments) from different individuals or the same individual at
different times varied significantly, between 250 to 550 RFU measured 1 h after
triggering OB. Data presented in this report are representative results of at least three
replicative experiments, unless otherwise stated, with neutrophils donated by different
individuals.

(I) NPY-induced enhancement of oxidative burst activities of normal neutrophils

Figure 1 depicts the OB activities of neutrophils treated with different
concentrations of NPY. Figure 1(a) shows the representative results of eight
experiments. Cells were pre-incubated with NPY for 18 h. An inverted U response
curve of OB with peak at 5 /xM was observed. Figure 1(b) presents the representative
results of seven experiments. The data were obtained from 4 h pre-incubation. NPY
produced a dose-dependent modulation of OB up to 20 /xM concentration.

In time course studies, cells were suspended in RPMI 1640 and 5 pM of NPY
was added to the culture at various time points. After the pre-incubation period, OB
activities of all cells were triggered at the same time. Data presented in figure 2
show the effect of NPY on OB activities of neutrophils when the cells were pre-
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Figure 1. Dose-dependent modulation of oxidative burst by NPY. Neutrophils
(1 x lOVwell) were incubated with various concentrations of NPY for (a) 18 h or
(b) 4 h. OB was then triggered with zymosan. Relative fluorescence intensity was
determined at 60 min after triggering. Each point represents the mean + SD of
triplicate samples. Asterisk denotes significant difference (p < 0.05) from control
without NPY.
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Figure 2. Time course of NPY modulation of oxidative burst in neutrophils.
Neutrophils (1 x lOVwell) were pipeptted in a 96-well tissue-culture plate and
incubated at 37°C in a 5% C02 incubator. NPY (5 /*M) was added to three different
wells at various intervals. OB activities in all neutrophils were then triggered with
zymosan at the same time after the incubation period. Relative fluorescence intensity
was determined 60 min after triggering. Each point depicts the mean + SD of
triplicate determinations. Asterisk denotes significant difference (p < 0.05) from
control not pre-incubated with NPY.
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exposed to the neuropeptide for various time periods. NPY induced a time-dependent
enhancement of OB. Pre-incubation time required for maximum responses varied,
between 18-24 h in five experiments.

(II) Specificity of NPY-induced potentiation of oxidative burst

The specificity of NPY-induced potentiation of OB was verified in two ways.
Non-specific peptides, poly-Ala-poly-Lys (11.6 kDa) and poly-Asp-Glu (7 kDa), were
tested for their modulatory effects on neutrophil OB. Neither peptides induced any
significant responses (Figure 3). The effect of anti-NPY antibody (Ab) on NPYinduced OB enhancement was examined. Figure 4a shows the OB activities of
neutrophils treated with NPY (5 /xM) alone, anti-NPY Ab (1:1,000 dilution) alone,
and NPY plus anti-NPY Ab. At 1.5 and 2 h after triggering OB, NPY-induced OB
response was significantly reduced by specific antibody. The kinetic curves of OB
produced by anti-NPY Ab and NPY antibody-antigen complex were essentially
identical. Non-specific Ab induced a similar kinetics of OB as anti-NPY Ab but did
not reduce the effect of NPY (Figure 4b).

(HI) Effect of NPY receptor subtype agonists on neutrophil oxidative burst activities

Figure 5 shows the OB activities of neutrophils treated with different
concentrations of PYY (a

and Y2 agonist), [Leu31, Pro34]NPY (a Yl5 Y3, and o
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Figure 3. Effect of non-specific peptides on oxidative burst. Neutrophils
(1 x lOVwell) were incubated with various concentrations of poly-Asp-Glu (7 KDa),
poly-Ala-poly-Lys (11.6 KDa) or NPY for 4 h. OB was triggered with zymosan.
Relative fluorescence intensity was determined 60 min after triggering. Each point
represents the mean ± SD of triplicate samples. Asterisk denotes significant
difference (p < 0.05) from controls without any peptides. Non-specific peptides did
not affect OB activities of neutrophils.
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OB was then triggered with zymosan. Fluorescence intensity of dichlorofluorescein was

determined every 30 min for 2 h, after triggering. Each point is the mean + SD of three samples. Corresponding time points
of anti-NPY Ab alone and NPY + anti-NPY Ab are not significantly different (p < 0.05) from each other. At 1.5 and 2
h, data points of NPY, control and set-ups with NPY are significantly different (p < 0.05) from each other, (b) Experiment
was set-up in the same way as in (a), except non-specific Ab from rabbit was used to replace anti-NPY Ab. Corresponding
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Figure 5. Effects of various NPY analogs on modulation of neutrophil oxidative
burst. Neutrophils (1 x lOVwell) were incubated with various analogs at three
different concentrations for 4 h. Relative fluorescence intensity was determined
60 min after triggering. Each point represents the mean + SD of triplicates. All
points are significantly different (p < 0.05) from control without any peptides.
Asterisk denotes significant difference (p < 0.05) from NPY of corresponding
concentration. PYY induced similar responses as NPY, while [Leu31,Pro34]NPY and
NPY 13-36 generated higher responses at 10 juM.
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agonist), and NPY 13-36 (a Y2, Y3, and o agonist). All the analogs were tested on the
same 96-well plate with NPY. Compared with NPY, similar responses were obtained
with various concentrations of PYY and 1 and 5 /xM of [Leu31,Pro34]NPY and
NPY 13-36* At 10 /iM, [Leu31,Pro34]NPY and NPY 13-36 induced significantly higher
responses.

(IV) Effect of NPY receptor subtype antagonists on neutrophil oxidative burst activities

The antagonistic effects of PYX-2 (a Yj antagonist) on NPY enhancement of OB
activities in neutrophils were studied. PYX-2 did not induced any significant
responses by itself and did not block the NPY induced responses (Figure 6). The
antagonistic effects of benextramine (a Yj, Y2 and a-adrenoceptor antagonist) and
haloperidol (a o antagonist) were also examined. Figure 7 shows that benextramine
or haloperidol alone induced OB enhancement in a dose-dependent fashion.
Haloperidol-induced augmentation was additive to the NPY enhancement of OB,
while benextramine and NPY together produced synergistic effects.
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Figure 6. Effect of PYX-2 (Yl antagonist) on NPY induced modulation of neutrophil
oxidative burst. The antagonist was added to the neutrophils 15 min before the
addition of 5 /xM of NPY. The culture was then incubated for 4 h. OB was
triggered with zymosan after the incubation period. Relative fluorescence intensity
was determined 60 min after triggering. Each point is the mean + SD of three
replicates. Corresponding points, with or without PYX-2, are not statistically
significantly different (p < 0.05), i.e. PYX-2 did not affect OB activities (0 /xM
NPY) and did not block NPY activities (5 /xM NPY).
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Figure 7. Effect of Y, & Y2 or a antagonists on NPY-induced modulation of
neutrophil oxidative burst. The antagonists were added to the neutrophils 15 min
before the addition of 5 /xM of NPY. The culture was then incubated for 4 h. OB
was triggered with zymosan after the incubation period. Relative fluorescence
intensity was determined 60 min after triggering. Each point is the mean + SD of
three replicates. Double asterisks denote significant difference (p < 0.05) from
control with NPY alone. Single asterisk denotes significant difference (p < 0.05)
from control without NPY. BEN=benextramine; HAL=haloperidol.
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DISCUSSION

Neutrophils are short-lived cells. Their half-life in the blood is approximately
6 h, while they remain functional for one or two days in the tissues (Drutz & Mills,
1984). We have found that the viability of neutrophils in vitro in RPMI 1640 after
24 h varied from 45-80% as determined by trypan blue exclusion. Overnight
incubation tended to produce larger standard deviations. For convenience and more
reproducible results, 4 h pre-incubation time was chosen for various experiments,
except for time course studies.

This report represents the first study of NPY in the context of human neutrophils.
In this study we showed that NPY could enhance oxidative burst activities of normal
neutrophils in vitro. The modulation was time and dose-dependent (Figures 1,2).
The dose required to produce any significant effect is much higher than the levels
detected in the blood (Irwin et al., 1991). However, micro-molar concentrations of
NPY were often used by other researchers for in vitro experiments (Merten &
Figarella, 1994). It was demonstrated that at high (micro-molar) concentrations, NPY
has a direct long-lasting constrictor action in some vascular beds, whereas at lower
(nano-molar) concentrations, it potentiates the action of other agents (Wahlestedt
et al., 1990a; 1990b). It is also possible that neutrophils can be exposed to high
concentrations of NPY for longer periods of time in localized area when subjects are
under chronic stress (Irwin et al., 1991). Our results indicate that lower
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concentrations may also produce significant effects if the immune cells are exposed to
the neuropeptide for a long period of time. NPY may be an important link in neuroimmune modulation in people under chronic stress. Moreover, NPY may be more
important in regulating the response of the immune cells to other modulating agents
than being a direct modulator itself.

The NPY-induced OB enhancement appeared to be specific, i.e. via specific
receptors, since non-specific peptides did not induce any responses (cf. Park et al.,
1994). Anti-NPY Ab essentially neutralized the NPY-induced effects (Figure 4a).
Changes in the kinetics of OB induced by antibody or immune complex were likely
mediated through the Fc receptors on the immune cells since non-specific Ab induced
a similar kinetics but did not neutralize the effect of NPY (Figure 4b). Fab fragment
of the antibody, if readily available, will be a better alternative for blocking
experiments when immune cells are used.

NPY binds to at least three different types of receptors, namely Yl3 Y2 (Michel,
1991; Wahlestedt et al., 1990a), and Y3 (Wahlestedt et al., 1991), and interacts with
sigma (Monnet et al., 1992a; 1992b; Roman et al., 1990) receptors. Peptide YY
(PYY) binds to both Y, and Y2 with higher or similar affinity as NPY and binds
poorly with Y3 (Wahlestedt et al., 1991). It does not interact with sigma receptors.
[Leu31,Pro34]NPY is a Y,, Y3 and sigma agonist (Dumont et al., 1993; Fuhlendorff
et al., 1990; Monnet et al., 1992a; 1992b) while NPY 13-36 is a Y2, Y3 and sigma
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agonist (Dumont et al., 1993; Michel et al., 1990; Monnet et aL, 1992a; 1992b). In
this study, PYY produced similar effects as NPY (Figure 5). This suggests that the
NPY receptor subtype on human neutrophils is neither the Y3 nor sigma subtype. If it
were, PYY would be expected not to give any response. [Leu31,Pro34]NPY and
NPY 13-36 induced similar or higher responses than NPY, indicating that the receptor
subtype on the neutrophils is not the Yj or Y2 subtype. If Y2 is involved, there
should be no response with [Leu31,Pro34]NPY.

Effective specific NPY antagonists are not yet available (Michel, 1991). We
tested several available antagonists to verify the results obtained from agonist studies.
PYX-2, a Y, receptor antagonist (McAuley & Westfall, 1992; Tatemoto, 1990), did
not block the NPY-induced enhancement of OB (Figure 6). Benextramine, a Yj and
Y2 as well as an a-adrenoceptor antagonist (Doughty et al., 1990; Li et al., 1991;
McAuley & Westfall, 1992), was shown to induce a dose-dependent augmentation of
OB. Instead of blocking the NPY-induced effect, benextramine further augmented the
NPY enhancement of OB in neutrophils (Figure 7). Haloperidol alone was also
shown to induce a dose-dependent enhancement of OB. It did not block the NPYinduced effect and its effect appeared to the additive to the effect produced by NPY
(Figure 7). These observations further suggest that the receptor for NPY on
neutrophils is not of Y,, Y2, Y3, or sigma. We are currently doing receptor binding
studies to confirm the findings in this report.
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In this investigation, only neutrophils from normal male donors were utilized.
Previous studies showed gender-related differences in various immune responses
including NK activity (Ferguson & McDonald, 1985; Grossman, 1985; Sulke et al.,
1985). Therefore, only male subjects were used to avoid confounding variables such
as the influences of hormones or the menstrual cycle.

Since the immune modulation can be affected by the physiological conditions of
the cell donors, it is desirable to develop an in vitro model. We attempted to develop
such a model using phagocyte cell lines. We tested four macrophage cell lines,
including J774.A1, Mono Mac 6, THP-1, and U937. All these cell lines have been
shown to be capable of producing oxidative burst. However, none of these cell lines
showed modulation responses by NPY. These cell lines are not terminally
differentiated cells and probably do not have receptors for NPY. The
unresponsiveness of the cell lines to NPY further supported that the reaction in
neutrophils was specific.
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ABSTRACT

Neuropeptide Y (NPY), arguably one of the most abundant peptides in the
nervous system, has previously been shown to modulate neutrophil oxidative burst
(OB) activity in a time- and dose-dependent manner, probably via a receptor that has
yet to be identified. We now further report that NPY did not affect the neutrophil
phagocytic function. NPY did not trigger OB by itself. Significant modulation of OB
required a long period of time (hours) after exposure but did not require the
continuous presence of NPY, indicating that the transduction of signal from the
receptor to the final effector is a slow process. NPY did not affect the activities of
mitochondrial dehydrogenases or the cytosolic non-specific esterases. Synthesis of
macromolecules was not shown to be involved in the modulation. Consumption of
oxygen was not significantly elevated while production of carbon dioxide was slightly
increased. These observations suggest that modulation of OB by NPY is a specific
effect, and is not due to a general activation of cellular enzymes or metabolic
activities. NPY induced an enhancement of OB triggered by zymosan and N-formylMet-Leu-Phe (FMLP), but not by phorbal myristate acetate (PMA), indicating that the
modulation of OB was not on the NADPH-oxidase or the protein kinase C.
A calmodulin inhibitor slightly enhanced the modulatory effect of NPY, suggesting
that Ca++/calmodulin-dependent enzymes are not involved in the modulation pathway
and may be involved in the down-regulation pathway of the modulation.
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INTRODUCTION

Polymorphonuclear leukocytes play a prominent role in the host response to
infectious diseases. Neutrophils have been found to infiltrate tumors (Dallegri &
Ottonello, 1992). They also have a role in other pathological inflammatory reactions
such as septic shock, adult respiratory distress syndrome (Gadek, 1992; Windsor
et al., 1993), and rheumatoid arthritis (Kitsis & Weissmann, 1991). The generation
of reactive oxygen species by the process of oxidative burst (OB) is considered a
major mechanism by which phagocytes mediate their antimicrobial and tumoricidal
functions (Babior, 1992). Many substances, generally called triggering agents, are
able to induce the sequence of reactions while other substances, called modulating
agents, can modify the magnitude of the response (Babior, 1992). Some triggering
agents can also act as modulating agents, usually at a lower concentration, e.g.
phorbal myristate acetate (Tyagi et al., 1988).

Neuropeptide Y (NPY) is a 36 amino acid peptide with an amidated C-terminal
(Tatemoto et al., 1982; Tatemoto, 1982). It is now thought to be an important
neurotransmitter. It is involved in the regulation of many physiological processes
such as feeding, anxiety, sexual behavior, and blood pressure (Wahlestedt et al.,
1990). Recent studies suggest that NPY may play a role in the modulation of immune
functions. Nerves containing NPY have been found to innervate immune organs
(Romano et al., 1991; Weihe & Krekel, 1991). NPY has been demonstrated to have
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variable effects on the proliferation of lymphocytes (Johansson & Sandberg, 1989;
Jones eta 1., 1990; Soder & Hellstrom, 1987), and to suppress natural killer (NK) cell
activity in vitro (Nair et al., 1993). Its plasma level has been shown to increase in
people under chronic stress and correlate with a decrease in NK activity (Irwin et al.,
1991).

We have recently shown that NPY can modulate the OB activity in human
neutrophils, probably via a receptor that has not yet been described (Wan & Lau,
1994b). The modulation is time- and dose-dependent. It requires 18-24 h before a
maximal effect is obtained. This corresponds to the effect produced by NPY in other
physiological systems, i.e. the induced-effect is a slow response (Wahlestedt et al.,
1990). We now report our probe into the mechanisms involved in the modulation of
OB by NPY.

137
MATERIALS AND METHODS

Reagents

Neuropeptide Y (NPY, human), poly-Ala-poly-Lys (11.6 kDa), poly-Asp-Glu
(7 kDa), zymosan A, pertussis toxin, cycloheximide, compound R24571,
5,6-dichlorobenzimidazole riboside (DRB), 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl
tetrazolium bromide (MTT), N-formyl-Met-Leu-Phe (FMLP), phorbal myristate
acetate (PMA), trypan blue, N,N’-dimethyl formamide (DMF), phosphate buffered
saline (PBS), and Hanks’ balanced salt solution (HESS) were all obtained from Sigma
Chemical (St. Louis, MO). 2,,7’-dichlorofluorescin diacetate (DCFH-DA),
calcein-AM, and fluorescein conjugated Escherichia coli K-12 bio-particles were
purchased from Molecular Probes (Eugene, OR). [14C(U)]glucose is from Moravek
Biochemicals, Inc. (Brea, CA).

All peptides were dissolved in HBSS, aliquoted, and stored at -20°C. Stock
solution of DCFH-DA was prepared in DMF at a concentration of 10 mM and stored
in the dark in nitrogen at -20°C. Zymosan was suspended in HBSS at a concentration
of 10 mg/ml and stored at 4°C. E. coli particles were suspended in HBSS, aliquoted
and stored at -20°C in the dark. The suspension was thawed and briefly sonicated just
before use. The bacterial cell number was determined visually with a Petroff-Hausser
counting chamber. Trypan blue was dissolved in citrate buffer, pH 4.4 (Sahlin et al.,
1983), at a concentration of 250 /xg/ml.
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Blood donors

Permission for using human subjects was obtained from Loma Linda University
Institutional Review Board (protocol #93110). Donors were healthy, adult, male
subjects. All donors were apprised of this study and informed consents were obtained
consistent with the university policy. Subjects were free of medical or psychiatric
illness and were not taking any medications, including nonsteroidal anti-inflammatory
agents and substance of abuse. Their mean age was 27.67 years, ranging between 23
and 42 years.

Leukocyte preparation

Blood from the cubital vein of healthy volunteers was collected in Vacutainer
tubes (Becton Dickinson, Lincoln Park, NJ) with 143 USP units of sodium heparin
per 10 ml of blood. Polymorphonuclear leukocytes were separated from whole blood
by the one step Hypaque-Ficoll method (Ferrante & Thong, 1980). Briefly, 5-7 ml of
whole blood were layered on 4 ml of the Neutrophil Isolation Medium (NIM) (Los
Alamos Diagnostics, Los Alamos, NM), and centrifuged at 400 x g for 40 min at
room temperature. The neutrophils were found in a separate band in the NIM below
the mononuclear cells and above the erythrocytes. The neutrophils were harvested
and washed twice with PBS. After being resuspended in HBSS, their numbers were
adjusted to 1 x 106 cells/ml.
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All assays, unless otherwise stated, were performed using flat-bottom 96-well
tissue culture plates (Coming, Los Angeles, CA). All the incubations were done in a
humidified 37°C and 5% C02 incubator. Fluorescence intensity in microtiter plates
was determined using an automated microplate fluorescence reader (Microplate
Fluorometer Model 7620; Cambridge Technology Inc., Watertown, MA) interfaced
with a DOS-compatible computer. Captured data were directly transferred to
statistics and graphics programs for analysis.

Phagocytosis assay

The phagocytosis assay was performed as previously described (Wan et al.,
1993a). Briefly, 100 /xl of cell suspension was pipetted into each well. The
modulating substance was added at this time. The plate was incubated for 4 h to
allow cells to adhere to the bottom of the wells. Then the culture medium was
aspirated. The E. coli suspension prewarmed to room temperature was briefly
sonicated to disperse any aggregates and 100 /xl were added to each well. The plate
was covered and incubated for 30 min. After incubation, the buffer in the plate was
removed by aspiration. Extracellular fluorescence was quenched by adding 100 /xl of
trypan blue (250 /xg/ml, pH 4.4). Wells containing only fluorescent particles were
used as controls to indicate complete quenching. After one minute, the dye was
removed. The fluorescence intensity (relative fluorescence unit, RFU) was
determined at 485 ± 10 nm excitation and 530 ± 12.5 nm emission wavelengths.
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Oxidative burst assay

The assay determining OB was previously described (Wan et al., 1993b). Cell
suspension (100 /xl) was pipetted into each well. If inhibitors were used, they were
pre-incubated with the cells for 2 h. NPY was added to a final concentration of
10 fxM. The plate was incubated for 4 h, unless otherwise stated. A triggering
agent, 100 fig of zymosan, together with 100 /xM DCFH-DA in 10 /xl of HBSS was
added to each well. The plate was covered with a lid and incubated for 60 min. The
fluorescence intensity (relative fluorescence unit, RFU) was determined at
485 + 10 nm excitation and 530 + 12.5 nm emission wavelengths. Variations in the
procedure is described in the Results section.

Mitochondrial dehydrogenase activities

Mitochondrial dehydrogenase activities were measured with MTT by a
modification of the method developed by Mosmann (1983). Neutrophils were
incubated with 10 /xM of NPY for 4 h. Then, 10 /xl of MTT solution (4 mg/ml) was
added and further incubated for 5 h. SDS was then added to each well to a final
concentration of 5 % and the plate was incubated overnight to dissolve the formazan
crystals. Absorbance was determined at 620 nm with an ELISA reader (model
400AT El A, Whittaker Bioproducts, Walkersville, MD).
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Cytosolic non-specific esterase activities

Cytosolic non-specific esterase activities were determined with calcein-AM
(Haugland, 1992). Briefly, neutrophils were incubated with NPY for 4 h. Then,
10 /-cl of calcein-AM was added. The plate was incubated for 1 h. The fluorescence
intensity (relative fluorescence unit, RFU) was determined at 485 ± 10 nm excitation
and 530 ± 12.5 nm emission wavelengths

Synthesis of macromolecules

The incorporation of radioactive [14C]glucose into neutrophils was employed for
estimating the synthesis of macromolecules (Hanson & Phillips, 1981). Neutrophils
(4 x 105 in 200 pi) were incubated with 10 /xM of NPY in the presence of 1 pCi of
[14C]glucose for 4 h in a borosilicated glass tube. Equal volume of 10% ice-cold
trichloroacetic acid (TCA) was then added. The tubes were incubated at 0°C for ten
minutes to precipitate all macromolecules. The precipitate was collected on a 0.4 pm
pore-size polycarbonate filter. Small molecules were washed away with 9 ml of 10%
ice-cold TCA. Filters were dried and the radioactivity was then counted in a
scintillation counter (Isocap/300, Nuclear Chicago, Chicago, IL).
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Determination of oxygen consumption and carbon dioxide production

Neutrophils (1 x 106 in 1 ml) were incubated with 10 pM of NPY for 4 h. The
cells were then drawn into a gas-impermeable syringe (Arterial blood sample syringe,
Concord/Portex, Keene, NH) and capped tight. The syringe was then incubated.
Oxygen and carbon dioxide tensions in the solution were determined with a blood gas
analyzer (Ciba-Coming Blood Gas System 288, Ciba-Coming Medfield, MN) at
various intervals by direct injection into the analyzer.

Statistical analyses

Data were expressed as the mean + SD. For multiple group comparisons,
one-way analysis of variance (ANOVA) was employed. Where ANOVA indicated
differences, Tukey’s multiple range tests for honestly significant difference (HSD)
were performed to specify the differences. ANOVA and multiple range tests were
performed with Statgraphics version 5 (STSC, Inc., Rockville, MD). Graphs were
prepared with SigmaPlot version 4.1 (Jandel Scientific, Corte Madera, CA).
Statistical significance was defined as p < 0.05.
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RESULTS

NPY did not modify the phagocytic process of neutrophils (Figure 1). In testing
whether NPY could trigger the OB process, various dilutions of NPY were added as
the triggering agent to wells containing cells and DCFH-DA. Fluorescence intensity
was determined after 1 h of incubation. NPY did not trigger the OB process at any
concentration. However, it lowered the fluorescence reading of spontaneous free
radical production or oxidation of DCFH-DA (Figure 2), presumably by scavenging
free oxygen radicals.

In determining the time requirement in the modulation process by NPY,
neutrophils were exposed to 10 /aM of NPY for 2 h, then the neuropeptide was
removed by washing the cells twice. Then the cells were further incubated for various
time periods. OB was triggered with zymosan. Figure 3 shows that continuous
presence of NPY was not required for the modulation, and the longer the post
incubation time, the stronger the effect.

The possible effects of NPY on the mitochondrial dehydrogenase and cytosolic
non-specific esterase activities were ascertained with MTT and calcein-AM,
respectively. Neither enzymes were affected by any concentration of NPY (Figure 4,
5). The oxygen consumption was not shown to be significant while the

144

Figure 1. Modulation of phagocytosis by NPY. Phagocytosis assay was performed as
described in Materials and Methods. Each data point represents the mean ± SD of
triplicate samples. All points are not significantly different (p < 0.05) from control
without NPY. Background represents the relative fluorescence of E. coli particles
adhered non-specifically to the tissue culture plate. Refer to chapter 4 for the
phagocytosis assay.
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Figure 2. NPY as an oxidative burst triggering agent. Neutrophils (1 x 105) were
pipetted into a 96-well tissue culture plate. Various concentrations of NPY (tested as
triggering properties) were added together with DCFH-DA. Relative fluorescence
intensity was determined 60 min after addition of NPY. NPY did not trigger
oxidative burst at any concentrations. However, it lowered the spontaneous free
radical production or oxidation of DCFH-DA, presumably by scavenging free oxygen
radicals or quenching the fluorescence of DCF. Each data point represents the
mean ± SD of triplicate samples. Asterisk denotes significant difference (p < 0.05)
from control without NPY.
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Figure 3. Post-incubation time and NPY-modulated oxidative burst. Neutrophils
(1 x lOVwell) were pipetted into a 96-well tissue culture plate and incubated at 37°C
in a 5 % C02 incubator. NPY (5 /xM) was added to different wells at different times
and then removed by washing after an exposure time. The set-up of the experiment is
illustrated as follows:
2h
a
b
c
d
e
f

2h

2h
M

mmm

i

WM

Shaded boxes represent exposure time to NPY. OB activities of all neutrophils were
triggered at the same time at the end of 9h. The enhanced effect on oxidative burst
was proportional to the length of post-exposure incubation time as well as to exposure
time, a: control, no exposure to NPY; b: 2h/3h (exposure/post-incubation); c: 2h/5h;
d: 2h/7h; e: 4h/3h; f: 6h/3h. Each data point represents the mean + SD of three
replicate samples. Asterisk denotes significant difference (p < 0.05) from control
without NPY.
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Figure 4. Effect of NPY on cytosolic esterase activties measured by calcein-AM.
Neutrophils (lx lOVwell) were incubated with various concentrations of NPY (5 /*M)
for 4h. Calcein-AM was then added to all cells. Relative fluorescence intensity of
calcein was determined after 60 min of incubation. Each data point represents the
mean ± SD of three replicate samples. None of the points is significantly different
(p < 0.05) from control without NPY.
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Figure 5. Effect of NPY on mitochondrial dehydrogenase activities measured by
MTT. Neutrophils (1 x 105/well) were incubated with various concentrations of NPY
(5 uM) for 4h. MTT was then added to all cells and the culture was further
incubated for 5 h and then processed according to Materials and Methods.
Absorbance was determined. Each data point represents the mean + SD of three
replicate samples. None of the points is significantly different (p < 0.05) from
control without NPY.
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Figure 6. Effect of NPY on the (a) consumption of 02 and (b) production of C02.
Experiments were carried out according to Materials and Methods. Each data point
represents the mean ± SD of three replicate samples. None of the points is
significantly different (p < 0.05) from control without NPY.
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production of carbon dioxide was slightly increased in neutrophils incubated with
NPY (Figure 6).

Synthesis of macromolecules was not increased by NPY (Figure 7). In
determining the involvement of protein synthesis in the modulation of neutrophil
functions, cycloheximide and DRB were used to block protein synthesis and RNA
transcription, respectively. Figure 8 shows that cycloheximide or DRB did not block
the effect induced by NPY. At high concentrations (5 and 25 /xg/ml, respectively),
both spontaneous and induced productions of oxygen free radicals were suppressed.

As an initial probe to the signal transduction pathway involved in the modulation
by NPY, various agents were used to trigger the NPY-modulated OB responses.
NPY enhanced the zymosan- and FMLP-triggered (5 x 105 M) reactions while it did
not change the PMA-triggered (0.01 ^g/ml) responses (TABLE I).

In order to ascertain the involvement of G-protein in the NPY-induced modulation
pathway, neutrophils were pre-incubated with pertussis toxin for 2 h. NPY was then
added and the culture was further incubated for 4 h. After the incubation period, the
cells were washed twice with warm HBSS. After another 3 h of incubation, oxidative
burst was triggered with zymosan. Pertussis toxin completely blocked the NPY
induced enhancement as well as lowered the spontaneous production of oxygen free
radicals (Figure 9).
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Figure 7. Incorporation of [14C]glucose into macro-molecules by neutrophils incubated
with or without NPY. Experiment was carried out according to Materials and
Methods, a: neutrophils with 5 % TCA added at the beginning of incubation;
b: culture medium alone; c: neutrophils without NPY; d: neutrophils incubated with
poly-Asp-Glu; e: neutrophils incubated with poly-Ala-poly-Lys; f: neutrophils
incubated with NPY. Radioactive glucose was added to each set-up. Each data point
represents three replicates. Asterisk denotes significant difference (p < 0.05) from
controls (a & b) while not significantly different from each other. NPY did not
induce any significant increase in incorporation of [14C]glucose above basal levels.
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Figure 8. Effect of protein synthesis and RNA synthesis inhibitors on NPY mediated
enhancement of oxidative burst. Neutrophils (1 x 105) were pipetted into each well.
Inhibitors were added 2 h before the addition of NPY. After 4 h of incubation with
NPY, OB was triggered with zymosan. Relative fluorescence intensity was
determined 60 min after triggering. Cycloheximide (a) and DRB (b) did not block
NPY mediated effects. At high concentrations (5 jitg/ml and 25 /xg/ml for
cycloheximide and DRB, respectively), neutrophils incubated with or without NPY
exhibited lowered oxidative burst responses, probably due to metabolic toxicity. Each
data point represents three replicates. Asterisk denotes significant difference
(p < 0.05) from corresponding controls with same concentration of inhibitor but
without NPY.
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TABLE I. OXIDATIVE BURST TRIGGERED BY VARIOUS AGENTS.
Neutrophils were incubated with NPY for 4 h. Oxidative burst was then triggered by
various agents. Neutrophils incubated without NPY were used as controls.

Fluorescence Intensity (RFU)
Agents

With NPY

Control

% increase

Zymosan

785 ± 20

623 ± 31

26.0*

FMLP

272 ± 9

215 ± 6

20.9*

PMA

4639 ± 327

4419 ± 119

4.9

* Statistically significant.
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Figure 9. Inhibition of NPY-mediated modulation by pertussis toxin. Neutrophils
(1 x 105) were pipetted into each well. Various concentrations of pertussis toxin were
added 2 h before the addition of NPY. After 4 h of incubation with NPY, OB was
triggered with zymosan. Relative fluorescence intensity was determined 60 min after
triggering. Pertussis toxin completely blocked the NPY-mediated enhancement of
oxidative burst responses. Each data point represents three replicates. Asterisk
denotes significant difference (p < 0.05) from corresponding controls without NPY.
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Involvement of Ca++/calmodulin-dependent kinases was also determined using the
same procedure. Neutrophils were pre-incubated with compound R24571, a
calmodulin inhibitor. At high concentration, the agent was toxic to the neutrophils.
At low concentration, NPY-induced enhancement was not blocked, but enhanced
further (Figure 10).
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Figure 10. Effect of compound R24571, a calmodulin inhibitor, on NPY mediated
enhancement of oxidative burst. Neutrophils (1 x 105) were pipetted into each well.
Various concentrations of compound R24571 were added 2 h before the addition of
NPY. After 4 h of incubation with NPY, OB was triggered with zymosan. Relative
fluorescence intensity was determined 60 min after triggering. Compound R24571 did
not affect oxidative burst by itself and did not block the NPY-mediated effect. At
25 /xg/ml, compound R24571 was toxic to neutrophils. Each data point represents
three replicates. Asterisk denotes significant difference (p < 0.05) from
corresponding controls without NPY.
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DISCUSSION

In this investigation, only neutrophils from normal male donors were utilized.
Previous studies showed gender-related differences in various immune responses
including NK activity (Ferguson & McDonald, 1985; Grossman, 1985; Sulke, 1985).
Therefore, only male subjects were used to avoid confounding variables such as the
influences of hormones or the menstrual cycle.

NPY has previously been shown to modulate the OB response in human
neutrophils (Wan & Lau, 1994b). Some agents that are able to trigger OB have been
shown to also modulate the response when used at a much lower concentration. For
example, PM A, at low concentration, can prime the OB by inducing the translocation
of protein kinase C from cytosol to the plasma membrane (Babior, 1992). In the case
of NPY, it modulates the OB in human neutrophils while it does not trigger the
reaction.

Significant enhancement of OB by NPY requires a minimum amount of
pre-incubation time (2 h), and reaches a maximum effect after 18-24 h. In this
report, we demonstrated that while a period of incubation time was required for the
modulation, the continuous presence of the neuropeptide was not. Once the ligand
bound to the receptors, signal was transduced to the inside of the cells. The fact that
the effect induced by NPY in neutrophils was a slow response corresponds to other
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physiological processes mediated by the neuropeptide (Wahlestedt et al., 1990). The
fact that continuous presence of the peptide was not required suggests that the downregulation of the NPY-induced effect is also a slow process. This is in contrast to the
OB process that is almost immediately reversed as soon as the ligand is removed.
For example, FMLP induces phosphorylation of a 47KDa protein involved in OB.
The 47KDa protein is immediately dephosphorylated upon the removal of the ligand
(Babior, 1992).

In order to determine whether the enhancement of oxidative burst by NPY was
due to a general activation of the metabolic activities of the neutrophils, we checked
the mitochondrial dehydrogenase, cytosolic non-specific esterases, consumption of
oxygen, and production of carbon dioxide. The results indicated that NPY did not
alter cellular enzyme activities or cause a major increase the metabolic activities of
the neutrophils. The modulation of oxidative burst is likely to be a specific effect.

Since the modulation of OB required a rather long period of time (hours), we
investigated whether synthesis of new molecules were involved in the process.
Synthesis of macromolecules induced specifically by NPY was not detected.
Cycloheximide, a protein synthesis inhibitor, and DRB, an RNA synthesis inhibitor,
did not completely block the NPY-induced effect. At high concentrations, both
compounds lowered the NPY-modulated and spontaneous oxidative burst. This is
probably due to a lowering of general metabolic functions. From these observations,
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we suggest that synthesis of new macromolecules is not required for NPY-induced
modulation.

In probing the signal transduction pathway involved in the modulation, zymosan,
FMLP, and PMA were used as triggering agents. The fact that NPY did not enhance
OB triggered by PMA suggests that the modulation process does not involve PKC or
any parts of the NADPH oxidase.

All the NPY receptors that have been described so far have been shown to
interact with pertussis toxin sensitive G-proteins (Michel, 1991; Wan & Lau, 1995).
Although the NPY receptors on neutrophils are likely to be a new receptor type that
has not been described (Wan & Lau, 1994b), they may also interact with pertussis
toxin sensitive G-proteins (Michel, 1991). In this study, pertussis toxin completely
blocked the NPY-mediated effects, indicating that a G-protein may be involved in the
signal transduction pathway (Babior, 1992). However, this is not conclusive since
pertussis toxin also blocks the triggering pathway. Other approaches are required to
confirm the involvement of a G-protein.

NPY has been shown in some other systems to increase the intracellular calcium
ion concentration (Michel, 1991). We used a calmodulin kinases inhibitor, compound
R24571, to investigate the involvement of Ca++/calmodulin dependent enzymes. Our
results indicate that these enzymes are not involved in the modulation pathway
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mediated by NPY. However, compound R24571 augmented the NPY-mediated
effect. One possible explanation is that calmodulin is involved in the down-regulation
of the modulation. Inhibition of the down-regulation in turn enhances the modulatory
effect.

In summary, NPY did not trigger OB but did enhance the response in human
neutrophils. The enhancement was a slow process and did not depend on the
continuous presence of the neuropeptide. The modulation process was not caused by
a general metabolic activation of the neutrophils, and did not appear to depend on
synthesis of macromolecules. The modulation of OB did not involve the NADPHoxidase, the protein kinase C, or any Ca++/calmodulin-dependent enzymes.
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CHAPTER 7
DISCUSSION

The idea of a functional connection among the nervous, endocrine and immune
systems is now accepted. This connection has been supported by the observation that
peptides from nervous or endocrine systems have receptors on immune cells and
modulate the function of such cells. NPY, originally isolated from porcine brain
(Tatemoto et al., 1982), has an important role as neurotransmitter or neuromodulator
in the nervous system. Studies in some animal species have established the
widespread distribution of NPY in both central and peripheral neurons, so that it is
considered as a chemical messenger and an ubiquitous marker of the nervous system
tissue. In addition, NPY has been found in nerve endings in immunocompetent
organs.

The effects of these peptides on the immune system have been scarcely studied.
NPY has been hypothesized to regulate the immune system, because this neuropeptide
has been found in spleen nerve terminals (Romano et al., 1991). Moreover,
circulating concentrations of NPY have been shown to be inversely correlated with
natural killer (NK) cell activity in depressed patients (Irwin et al., 1991). The effect
of this peptide on immune cells has only been investigated on proliferation of
lymphocytes in vitro, producing no change on spontaneous lymphoproliferation
(Johansson & Sandberg, 1989) or a decrease in the proliferative response to mitogen
174
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PHA (Soder & Hellstrom, 1987). The aim of the present work was to study the
effects in vitro of NPY on the phagocyte function. Human neutrophils were used as a
phagocyte model since they could be easily obtained in large quantities.

As commercial synthetic NPY was costly, three sensitive immune function assays
that utilized small volumes so as to conserve the use of the neuropeptide as well as
the human cells were developed. Two of the assays were used in this project. The
assays utilize cutting-edge fluorescence technology. The 96-well micro-titer plate
format and multi-channel pipettor allow rapid processing of a large number of
samples.

In this investigation, only neutrophils from normal male donors were utilized.
Previous studies showed gender-related differences in various immune responses
including NK activity (Ferguson & McDonald, 1985; Grossman, 1985; Sulke et al.,
1985). Therefore, only male subjects were used to avoid confounding variables such
as the influences of hormones or the menstrual cycle.

In this study, we showed that NPY could modulate oxidative burst (OB) triggered
by zymosan in human neutrophils while it has no effects on the phagocytosis process.
NPY did not trigger but enhanced OB in a time and dose-dependent fashion. The
dose required to produce any significant effect is much higher than the levels detected
in the blood (Irwin et al., 1991). However, micro-molar concentrations of NPY were
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often used by other researchers for in vitro experiments (Merten & Figarella, 1994).
It was demonstrated that at high (micro-molar) concentrations, NPY has a direct longlasting constrictor action in some vascular beds, whereas at lower (nano-molar)
concentrations, it potentiates the action of other agents (Wahlestedt et al., 1990a;
1990b). It is also possible that neutrophils can be exposed to high concentrations of
NPY for longer periods of time in localized area when subjects are under chronic
stress (Irwin et al., 1991). Our results indicate that lower concentrations may also
produce significant effects if the immune cells are exposed to the neuropeptide for a
long period of time. NPY may be an important link in neuro-immune modulation in
people under chronic stress. Moreover, NPY may be more important in regulating
the response of the immune cells to other modulating agents than being a direct
modulator itself.

The reaction appeared to be specific, i.e. via specific receptors, since non-specific
peptides did not produce any significant effects, and anti-NPY antibody essentially
neutralized this enhancement while antibody which was non-specific for NPY did not
block the modulation.

Modulation of neutrophil OB by NPY is likely to involve an atypical receptor that
has not been described in the literature since peptide YY (PYY), [Leu31,Pro34]NPY,
and NPY C-terminal fragment 13-36 induced comparable responses as NPY and none
of the known receptor antagonists could block the NPY-induced modulation.
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Significant enhancement of OB by NPY requires a minimum amount of pre
incubation time (2 h), and reaches a maximum effect after 18-24 h. While a period
of incubation time was required for the modulation, the continuous presence of the
neuropeptide was not. Once the ligand bound to the receptors, signal was transduced
to the inside of the cells. The fact that the effect induced by NPY in neutrophils was
a slow response corresponds to other physiological processes mediated by the
neuropeptide (Wahlestedt et al., 1990a). The fact that continuous presence of the
peptide was not required suggests that the down-regulation of the NPY-induced effect
is also a slow process. This is in contrast to the OB process that is almost
immediately reversed as soon as the ligand is removed. For example, FMLP induces
phosphorylation of a 47KDa protein involved in OB. The 47KDa protein is
immediately dephosphorylated upon the removal of the ligand (Babior, 1992).

The enhancement of OB was not due to a general activation of metabolism of the
neutrophils since the cytosolic non-specific esterases (measured by calcein-AM), the
mitochondrial dehydrogenases (measured by MTT), and oxygen consumption were not
affected by NPY.

Synthesis of macromolecules is probably not involved in the modulation process
since cycloheximide (a protein synthesis inhibitor) and DRB (an RNA synthesis
inhibitor) did not block the modulation. NPY enhanced the OB triggered by zymosan
and FMLP, but not by PMA. This indicated that the modulation does not involve
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protein kinase C or NADPH-oxidase. Compound R24571 (a calmodulin inhibitor) did
not affect the oxidative burst process or inhibit the NPY modulation, indicating that
Ca++/calmodulin dependent enzymes are not involved in the modulation process.

In summary, NPY did not trigger OB but enhanced the response in human
neutrophils, probably via an atypical receptor that has not yet been described. The
enhancement was a slow process and did not depend on the continuous presence of
the neuropeptide. The modulation process was not caused by a general metabolic
activation of the neutrophils, and did not appear to depend on synthesis of
macromolecules. The modulation of OB did not involve the NADPH-oxidase, the
protein kinase C, or any Ca++/calmodulin-dependent enzymes.
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APPENDIX I
Oxidative Burst:
The Enzyme, Triggering, and Priming Processes

One of the mechanisms used by phagocytes to mediate their antimicrobial and
tumoricidal functions is a very complex group of highly reactive chemical agents that
destroy invading microorganisms through nonspecific oxidation (Babior, 1978; 1979;
Murray and Cohn, 1980). These agents, include oxidized halogens, oxidizing
radicals, and (in the case of eosinophils) singlet oxygen, are generated by the partial
reduction of oxygen via a metabolic pathway that is activated with appropriate stimuli.
The production of these agents is associated with an abrupt increase in the
consumption of oxygen which has nothing to do with respiration by the phagocytes.

All the lethal oxidants released by activated phagocytes are ultimately derived
from the superoxide anion, 02'. The key enzyme of the respiratory burst is therefore
the enzyme responsible for 02 production. This enzyme, a unique pyridine
nucleotide oxidase so far found only in phagocytes and, in much smaller quantities, in
B lymphocytes, manufactures 02 according to the following reaction:
202 + NADPH
202 + 2H+

> 202 + NADP+ + H+

> o2 + h2o2

This enzyme is sometimes referred to as "NADPH oxidase", "respiratory burst
oxidase", or "oxidative burst oxidase". This appendix is intended only for a quick
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review. Readers are directed to a recent article (Babior, 1992) for more information.
The following paragraphs summarize the information reviewed is this article.

Components of the Oxidative Burst Oxidase

In studying a cell-free system from activated neutrophils, the 02 -forming activity
was found to be associated exclusively with the plasma membrane. In the membrane
the oxidase is vectorially disposed, with its NADPH binding site extending into the
cytoplasm and its 02 -releasing site facing the cell exterior (or the vesicle lumen, in
the case of a phagocytic vesicle). Recent advances have revealed the respiratory burst
oxidase to be a highly complex biochemical species whose activity depends on the
interaction of a large number of polypeptide components, some currently known and
others yet to be discovered. The oxidase components in the resting cell are not
situated exclusively in the plasma membrane, but are distributed between the
membrane and the cytosol. Seven oxidase components have so far come to light
(Babior, 1992). Four of these components appear to be in the cytosol, and three in
the plasma membrane (Figure 1). The cytosolic as well as the membrane components
usually exist as complexes. During activation (triggering) of oxidative burst oxidase,
the cytosolic complex migrates to the plasma membrane.
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Figure 1. Components of respiratory oxidase. The exact configuration of the oxidase
complex is not known. This figure is drawn according to the information available at
this point. Please refer to text for explanation.
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Cytosolic components
Purification procedures have been developed to separate the cytosolic oxidase
components from each other, detecting fractions that contain oxidase components
by measuring each fraction’s ability to stimulate 02' production in cell-free systems
supplemented with other cytosolic fractions or with limiting amounts of normal
cytosol. These procedures have indicated that neutrophil cytosol contains at least four
separate oxidase components.

p47pbox: This polypeptide contains variable numbers of phosphate groups, all as
phosphoserine. Unphosphorylated p47phox is restricted to resting cells, where it is
found only in the cytosol, whereas the phosphorylated forms are restricted to activated
cells, where they are distributed between the cytosol and the plasma membrane. The
most extensively phosphorylated form of p47phox, however, is found only in the
plasma membranes, where its appearance depends on the presence of gp91phox, the
large subunit of cytochrome b558. These observations suggest that the initial
phosphorylation involves a cytochrome b558-dependent reaction that takes place on the
plasma membrane, and that p47phox can be transferred from the cytosol to the plasma
membrane only after attaining some level of phosphorylation. This protein is
probably not an essential component of the active oxidase, but is required only the
activation process. This protein has recently been cloned. Analysis of the sequence
revealed a very basic C-terminal region with several potential phosphorylation targets,
as well as regions of similarity to the following: (i) a GTPase-activating protein that
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interacts with the proto-oncogene p21nw; (ii) a src tyrosine kinase regulatory region;
(iii) a phosphatidylinositol-specific phospholipase C; and (iv) a-fodrin, a non
erythrocyte spectrin.

p67phox; It is found to be associated with the Triton-insoluble cytoskeleton in both
resting and activated neutrophils. This protein has been cloned. Sequence analysis
shows an acidic C-terminal region and two stretches 51 amino acids long that are
similar to each other and to a variety of proteins that interact with the cytoskeleton.
The function of p67phox is not known. Some evidence suggests that it may participate
in oxidase activation through a conformational change induced by binding to an
anionic lipid.

p32phox: This is the NADPH-binding subunit of the oxidase. In resting neutrophils
this component is in the cytosol and is transferred to the plasma membrane when the
oxidase were activated.

Krev-1 (rapl): Evidence has recently been obtained strongly suggesting that this 22K
GTP-binding protein is the oxidase-controlling G protein in the human neutrophil
(Benna et al., 1994). In neutrophils, Krev-1 is found principally in the cytosol.
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Membrane-associated Components
gp91phox: Cytochrome b558, generally held to be the terminal electron carrier of the
respiratory burst oxidase, is a heterodimer containing a 9IK subunit and a 22K
subunit. Both of these subunits are integral membrane proteins. The 9IK subunit is
a cationic transmembrane glycoprotein that consists of a 53K polypeptide variably
glycosylated with N-linked oligosaccharides of the complex type. The gene for
gp91 Pho* is the first oxidase gene to be cloned and sequenced. Sequence analysis
shows that gp91phox is an integral membrane protein with three transmembrane
segments, five N-glycosylation sites on the external side of the membrane, and a
carboxy-terminal cytoplasmic tail of considerable length. The protein also contains
sequences that attach it to the cytoskeleton.

There is some evidence that the C-terminal cytoplasmic tail of gp91phox
participates directly in the interaction between the cytoplasmic and membrane-bound
oxidase components that develops when the respiratory burst oxidase is activated.
The transfer of p47phox to the membrane occurs at least in part through the direct
binding of p47phox to the cytoplasmic tail of gp91phox.

p22phox: It is a non-glycosylated 22K polypeptide that was found to accompany
gpqjphox gyring the purification of cytochrome bjsg. Sequence analysis shows one
hydrophobic domain that can represent a transmembrane region. It may also be the
heme-bearing component of cytochrome b558-
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p45phox: This is probably a membrane-associated oxidase flavoprotein. The existence
or non-existence of a membrane-associated oxidase flavoprotein remains to be
established.

Activation, Deactivation, and Inactivation of the Respiratory Burst Oxidase

The respiratory burst oxidase of the phagocyte normally exists in a dormant state,
acquiring catalytic activity only when the cell is called into action by exposure to an
appropriate stimulus. Activation of the respiratory burst oxidase in intact neutrophils
can be accomplished by a large number of agents, some acting through receptors and
others acting more directly on the oxidase activating apparatus. Examples of agents
acting through receptors include antigen-antibody complexes, which activate the
oxidase when bound to the Fcyll receptor, and the chemotactic peptide N-formylmethionyl-leucy 1-phenylalanine (FMLP), which binds to a formyl-peptide receptor to
activate the enzyme. Agents that act at a point in the signal transduction pathway
distal to the receptors include phorbol myristate acetate, an activator of protein kinase
C, and the fluoride anion (F), which is thought to act through a G protein.

Once activated, the oxidase usually persists in its activated state until it is
destroyed by the products of its own activity. Using activating agents that can be
removed from the system, however, it has been shown that oxidase activation is in
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principle a reversible process: the oxidase in an activated neutrophil returns to its
dormant state (i.e., deactivated) when the stimulus is withdrawn, and is reactivated
when the cell is exposed a second time to an activating stimulus. Deactivation is
associated with dephosphorylation of the 47K phosphoprotein, and reactivation with
the rephophorylation of this protein. In fact, there is some evidence suggesting that
the respiratory burst oxidase in activated neutrophils is continuously undergoing
activation and deactivation, and that the level of oxidase activity measured at any
given time represents a steady state that is determined by the relative rates of
activation and deactivation that are taking place at the time the measurement is made.

Triggering Signalling Pathway

Figure 2 is a composite pathway from various reports. The signalling pathway
involves a number of steps. Readers are directed to a recent review article
(Baggiolini et al., 1991) for more information.

Receptor occupancy
The respiratory burst is initiated by the binding of the agonist to its receptor and
is rapidly discontinued when the agonist is displaced, suggesting the persistence of the
agonist-receptor complex is necessary to maintain the oxidase in it active form.
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Figure 2. Triggering pathways of oxidative burst. The exact pathways for activation
of the oxidase complex is not known. This figure is drawn according the information
available at this point. Please refer to text for more detail.
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GTP-binding proteins
The involvement of GTP-binding proteins in receptor-mediated neutrophil
activation was suggested by the blocking effect of pretreatment with Bordetella
pertussis toxin. The observation that fluoride and, in electro-permeabilized cells, the
non-hydrolyzable GTP analogue, GTP[S] (guanosine 5’-[7-thio]triphosphate) can
substitute for the agonist further suggests the involvement of a G-protein.
Pertussistoxin renders the neutrophils unresponsive to agonists, but the respiratory
burst can still be elicited by stimuli like phorbol esters, diacylglycerols or calcium
ionophores that bypass receptors.

Second-messenger generation
Upon receptor-ligand interaction and coupling to a G-protein, two second
messengers are formed (through the activation of a phosphatidylinositol-specific
phospholipase C): inositol 1,4,5-triphosphate (IP3) and diacylglycerol (Park and
Babior, 1992; 1993). IP3 is released into the cytosol and binds to specific receptors
on intracellular calcium storage organelles inducing a rise in cytosolic free calcium,
while diacylglycerol remains associated with the membrane and activates protein
kinase C.

The role of cytosolic free calcium
The increase in cytosolic free calcium reflects calcium release from intracellular
stores and influx through the plasma membrane. The influx is not essential since
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neutrophils respond in the absence of extracellular calcium. However, when the
intracellular stores are depleted of calcium (using an ionophore and intra- and
extracellular chelators), the respiratory burst is prevented. In calcium-depleted cells
diacylglycerol is not formed and, consequently, protein kinase C remains inactive.
Under these conditions a respiratory burst is nevertheless observed in response to
agonists when the kinase is activated by the addition of a phorbol ester or exogenous
diacylglycerol, indicating that once the kinase is turned on, activation of the
respiratory oxidase is independent of calcium mobilization.

Protein kinase C
A role for protein kinase C (Gennaro et al., 1986; Cox et al., 1985) and protein
phosphorylation in the induction of the respiratory burst is suggested by the
stimulatory effect of PM A and diacylglycerol, and the inhibitory effects of
staurosporine, sphingosine bases and other kinase inhibitors. The response induced
by phorbol esters and diacyglycerols, however, is much slower than that resulting
from receptor activation, indicating that protein kinase activation is only part of the
signal transduction process initiated by receptor agonists.

A dual signal transduction pathway
The observations obtained using inhibitors and calcium depletion indicate that the
activation of the respiratory burst by chemotactic agonists depends on two signal
transduction sequences. One is calcium-dependent and leads to the activation of
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protein kinase C, while the other is calcium- and protein kinase C-independent and
sensitive to 17-hydroxywortmannin (Dewald et al., 1988). Since the respiratory burst
response to agonist can be prevented by either calcium depletion or treatment with
17-hydroxy wortmannin, it appears that both processes must be acting in concert.
Another study suggests that a transmethylation reaction may be involved in the
activation process (Pick and Mizel, 1982).

Priming Process

Priming is a process in which a stimulus, though not itself competent to activate
the oxidase, increases the level to which the enzyme is subsequently activated by a
competent stimulus. Standard oxidase activating agents (e.g., phorbol myristate
acetate) can prime the enzyme if used at sub-stimulatory concentrations, but priming
is more characteristic of agents that by themselves have little ability to activate the
oxidase: endotoxin, platelet activating factor, diacylglycerol (Bass et al., 1987) and
alky lacy Iglycerol, and several cytokines, including IL-1, GM-CSF, and tumor
necrosis factor. Little is known about how priming is accomplished, though protein
phosphorylation and changes in cytosolic calcium concentration and in the properties
of protein kinase C have been proposed as possible mechanisms.

In conclusion, oxidative burst is a complex and well-orchestrated phenomenon.
The enzyme complex, the triggering, and the priming processes are not yet fully
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known. This appendix provides only a quick review of what has come to light.
Readers are encouraged to refer the references listed for more information.
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ABSTRACT

A sensitive fluorometric assay was developed for the enumeration of cells in
microtiter plates. This assay is based on the fluorescence enhancement of propidium
iodide (PI) upon binding with double-stranded nucleic acids. This fluorochrome is
compatible with a wide range of reagents commonly used in the laboratory, thus
washing the cells before staining is not necessary. PI, together with Triton-X 100 and
EDTA, was added directly to the cell culture. After 16-18 h incubation at room
temperature, intensity of fluorescence was determined with a micro-plate fluorometer.
This quick and simple method is sensitive for as little as 1.95 x 103 mononuclear
leukocytes, and provides a linear correlation (r = 0.999) between cell number and
fluorescence up to 1 x 106 cells. Since PI has a large Stokes shift with excitation
wavelength at common visible range and emission wavelength far out in the red
region of the spectrum, it allows simultaneous detection of DNA and other fluorescent
compounds such as calcein and fluorescein. This assay may prove to be a valuable
alternative for cell number determination.
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INTRODUCTION

Studies involving cultured cells often require the quantitation of cells in a large
number of samples under various conditions. Numerous methods have been described
in the literature. Direct approaches include visual counting under microscope or
electronic counting using a particle counter or flow cytometer. Visual counting is
slow and labor intensive. Adherent cells may not be completely dislodged and
resuspended in solution, and cells may clump together making it difficult to have
accurate assessment with an electronic counter. Techniques using monoclonal
antibody against DNA (Faraji-Shadan & Bowman, 1989) or crystal violet staining
(Gillies et al., 1986) have been described. These methods are either laborious or
incapable of producing consistent readings.

Other indirect methods measure either certain enzyme activity or the content of
certain substance in the cells. A colorimetric assay using MTT (Mosmann, 1983) or
XTT measures the mitochondrial dehydrogenases. Measuring peroxidase activity
using 0-dianisidine (3,3’-dimethoxybenzidine) (lunger et al., 1993) has been employed
to determine specifically polymorphonuclear leukocyte numbers. Fluorometric assays
determining non-specific cytosolic esterase activities using substrates such as
fluorescein diacetate, 4-methylumbelliferyl heptanoate (Dotsika & Sanderson, 1987;
Stadler et al., 1989), calcein-AM, or BCECF-AM have also been developed.

A

similar assay measures the alkaline phosphatase activity (Huschtscha et al., 1989).
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Although these assays are generally very sensitive, some capable of detecting as little
as 100 cells, their cell number and signal correlations reach a plateau at high cell
concentrations. Since their signal measurements can be affected by the length of
incubation as well as the cellular metabolic activity levels, unless a standard curve is
prepared alongside, it will be difficult to compare results from different experiments.
Moreover, if a substance that can modulate the enzyme activities is added in various
doses to different cultures, these assays will produce erroneous estimations.

Assays for cellular components such as ATP, protein, or DNA have been utilized
for cell counting. In the ATP assay, the signal varies since the ATP content of cells
changes from time to time (Crouch et al., 1993), and is affected by extracellular
factors or cellular metabolic activities (Partsch & Schwarzer, 1991). Assays for ATP
also require a luminometer that may not be available in many laboratories.
Measuring protein content (Lowry et al., 1951) is complicated by the presence of
serum used in cell cultures, and the assay is not sensitive for low cell numbers.

Various techniques for DNA quantitation can be found in the literature. These
assays are based on the fluorescence enhancement of the fluorochromes, such as
Hoechst 33342, Hoechst 33258, or 4,6-diamidino-2-phenylindole (DAPI), upon
binding with DNA (Adams & Storrie, 1981; Blaheta et al., 1991a; 1991b; Downs &
Wilfinger, 1983; McCaffrey et al., 1988; Papadimitriou & Lelkes, 1993). Although
they are not as sensitive as the enzyme assays, they can detect as little as one
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thousand cells (Blaheta et al., 1991b). Measuring DNA content appears to be the
ideal choice for cell number determination. DNA quantity is not affected dramatically
by the cellular enzyme activities, and correlates well with cell numbers over a wide
range. Moreover, the signals for each cell type remain relatively constant, allowing
estimation of cells without setting up a standard curve each time (Rago et al., 1990).

Since the fluorochromes used by previous investigators have excitation and
emission wavelengths common to substances used in cell culture (Bialek & Abken,
1991), washing steps to remove interfering substances are often required.

Except for

Hoechst 33342, permeabilization of the cell membrane is necessary. The
fluorochromes are also not compatible with the common permeabilizing agents used in
the laboratory, special treatment steps are required in these assays (Rago et al., 1990;
West et al., 1985). We now describe a quick and simple, yet accurate and
reproducible procedure for cell enumeration using propidium iodide (PI), a
fluorochrome which binds to double-stranded (ds) DNA and dsRNA, primarily by
intercalation. Since PI has a large Stokes shift (Haugiand, 1992), with excitation at
common visible wavelength and emission wavelength far out in the red region of the
spectrum, it eliminates the background autofluorescence from culture reagents and
cellular components, and allows simultaneous detection of DNA and other fluorescent
compounds such as calcein and fluorescein. This method may prove to be a valuable
alternative for the enumeration of cells.
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MATERIALS AND METHODS

Reagents

Hanks’ balanced salt solution (HESS), N,N’-dimethylformamide (DMF), Triton
X-100, heparin, HEPES, sodium dodecyl sulfate (SDS), and ethidium bromide (EB)
were obtained from Sigma Chemicals (St. Louis, MO). Propidium iodide (PI),
Hoechst (H) 33258, and Hoechst (H) 33342 were purchased from Molecular Probes
(Eugene, OR). Dulbecco’s modified Eagle’s medium (DMEM) and Roswell Park
Memorial Institute (RPMI) 1640 medium was from Cellgro (Santa Clarita, CA).
Fetal bovine serum (FBS) was supplied by HyClone Laboratories (Logan, UT).

PI, H33258, and H33342 were dissolved in distilled water at a concentration of
1 mg/ml. Small amount (< 0.5%) of DMF was added to facilitate dissolving PI.
All stock solutions were stored in the dark at 4°C. The stock solutions were further
diluted prior to each experiment. Proliferation medium (PM) was RPMI 1640,
without phenol red, supplemented with 10% heat-inactivated FBS, penicillin
(400 U/ml), streptomycin (200 jug/ml), 10 mM HEPES, and 0.01% mercaptoethanol.
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Cell line

A murine macrophage cell line, J774A. 1, was obtained from American Type
Culture Collection (ATCC) (Rockville, MD). This cell line has been described as a
reticulum cell sarcoma by Ralph et al. (1975; 1976; 1977), and used as a model for
oxidative burst (Wan et al., 1993a) and phagocytosis studies (Wan et al., 1993b).
J774 cells were grown in DMEM, supplemented with 7.5% heat-inactivated FBS,
penicillin (400 U/ml) and streptomycin (200 /xg/ml).

Cells were cultured at 370C in a humidified 5% C02 atmosphere for 3-4 days
before being used for experiments. The viability of cells used in experiments was
always greater than 97% as determined by trypan blue exclusion.

Mononuclear leukocytes and neutrophil preparation

Blood from the cubital vein of healthy volunteers was collected in Vacutainer
tubes (Becton Dickinson, Lincoln Park, NJ) with 143 USP units of sodium heparin
per 10 ml of blood. Polymorphonuclear leukocytes (PMN) and mononuclear cells
were separated from whole blood by the one step Hypaque-Ficoll method (Ferrante &
Thong, 1980). Briefly, 5-7 ml of whole blood were layered on 4 ml of the
Neutrophil Isolation Medium (NIM) (Los Alamos Diagnostics, Los Alamos, NM),
and centrifuged at 400 x g for 40 min at room temperature, after which the
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neutrophils were found in a separate band in the NIM below the mononuclear cells
and above the erythrocytes. The mononuclear cells and neutrophils were harvested,
and washed twice with HBSS without calcium. The viability of cells was greater than
99%. After being resuspended in PM, their numbers were determined visually with a
hemacytometer, and then adjusted to 1 x 107 cells/ml.

Cell number determination

Cells suspended in 100 ^1 of PM were two-fold serially diluted in a flat-bottomed
96-well tissue culture plate. Staining solution, containing PI (440 /xg/ml), Triton
X-100 (5.5%), and EDTA (110 mM) in a volume of 10 /*1, was added to each well
containing cells. Wells containing dye and PM only were included to give blank
values. The microplate was incubated at room temperature, and the intensity of
fluorescence (relative fluorescence unit, RFU) was determined at various time
intervals with a microplate fluorometer (Model 7620, Cambridge Technology,
Watertown, MA) at 540 ± 12.5 nm excitation (ex) and 620 + 20 nm emission (em).

Data analyses

Data were expressed as the mean + SD. Linear regression analyses and graphs
were prepared with SigmaPlot version 4.1 (Jandel Scientific, Corte Madera, CA).
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RESULTS

Background fluorescence determination

In preliminary experiments, we tested the compatibility of several DNA stains,
including H33258, EB, and PI, with solubilizing/permeabilizing agents commonly
used in the laboratory. SDS, at 0.05% or more, is found to increase the
autofluorescence of all fluorochromes. Triton-X 100 also increases the fluorescence
of H33258 and EB, but it does not dramatically affect the autofluorescence of PI
(Table I). We further tested other substances commonly used in tissue cultures for
possible interferences with various DNA stains. The background fluorescence of PI
was not dramatically affected by various agents (Table I). Triton X-100 and PI were
used for further studies.

Permeabilization and solubilization protocols

In preliminary experiments for cell number determination, cells were resuspended
in HBSS. Triton X-100, at a final concentration of 0.5%, was added to permeabilize
cells. PI, at a final concentration of 40 /xg/ml, was added. The intensity of
fluorescence was determined at various time intervals. Triton X-100, when added
alone, often caused cell aggregation, and thus produced erratically high or low
readings. When EDTA was added together with Triton X-100, cell clumping did not
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TABLE I
FLUORESCENCE DUE TO POSSIBLE INTERFERING SUBSTANCES.
Various agents were prepared in distilled water, except FBS in HBSS. The dyes
(10 /xl) were added to 100 //I of the agents to the final concentrations indicated in the
brackets. After thorough mixing, intensity of fluorescence was determined.
Relative Fluorescence*
Agents
NONE (Blank)
SDS
0.01%
0.05%
0.10%
Triton X-100
0.1%
0.5%
1.0%
FBS (15% in HBSS)
EDTA (10 mM)
HEPES (50 mM)
NaCl (100 mM)
Mercaptoethanol (2%)
PM
PM + Triton X-100 (0.5%)

H33258 (1 /xg/ml)8
1.000

EB (40 /xg/ml)b
1.000

PI (40 /*g/ml)b
1.000

1.049
1.122
3.756

0.943
1.597
7.222

0.940
1.625
3.448

2.927
3.047
3.366
2.407
1.000
1.069
1.034
0.828
1.310
3.827

1.833
4.016
5.505
2.797
0.919
0.913
0.896
0.880
1.015
3.946

1.001
1.056
1.110
1.333
0.981
0.991
0.984
0.907
0.914
1.253

1.929

7.249

11.532

0.826

3.756

15.577

+ EDTA (10 mM)

fPM + SDS (0.01%)
+ EDTA (10 mM)
+ 1 x 105 J774

fPM + Triton X-100 (0.5%)
+ EDTA (10 mM)
+ 1 x 104 J774

* ratio of the average fluorescence readings between wells with agents (A) added and blank (B) values,
i.e. A:B.
t ratio of the average fluorescence readings between wells with cells and corresponding suspension solution.
Excitation (ex) and emission (em) wavelengths are:
a 360 ± 17.5 ex and 460 ± 20 em, and
b 540 ± 12.5 ex and 620 ± 20 em.
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occur. EDTA also increased the fluorescence signal from DNA binding without
increasing the background.

We also developed an alternative solubilization protocol for situations with uneven
distribution of adherent cells in the wells. Triton X-100 (0.5%), together with 50 U
of heparin, was added to each well. The culture was incubated for 30 min or until
the cells were completely solubilized as determined under microscope. PI and EDTA
were then added. Fluorescence intensity was determined after incubation. The
intensity of fluorescence was identical in both protocols.

It was noted that if EDTA

was added together with Triton X-100 and heparin, cells would not be solubilized.

Time course offluorochrome-nucleic acids interaction and fluorochrome concentration

J774 cells suspended in PM were plated at cell concentrations from 488 to
5 x 105 cells/well, and stained according to the protocol with various concentrations
of PI. Multiple readings were obtained at various time points. Figure 1 represents
fluorescence associated with the highest cell density used (5 x 105 cells/well).
Different dye concentrations produced similar time-dependent curves. The staining of
nucleic acids almost reached saturation at 6 h.

A reproducible maximum was

obtained about 16 h after application of the dye, and the readings were stable even
after 27 h. Lower cell densities showed a similar time-dependent binding (data not
shown).
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Figure 1. The time-course of fluorochrome-nucleic acids interaction. J774 cells
(5 x lOVwell) were stained with 20, 40, and 60 /xg/ml of PI. Multiple readings were
taken at various time points. Each point represents the mean ± SD of triplicate
measurements.

Error bars, if not indicated, are masked by the symbols.
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J774 cells and neutrophils suspended in PM were two-fold serially diluted, and
stained with various concentration of PI for 16-18 h (Figure 2). The amount of
fluorochrome required depended on the total amount of nucleic acids present. A final
concentration of 40 ^g/ml of PI was chosen for our protocol since it provided an
excellent linear correlation between fluorescence and cell numbers, and a minimal
background of autofluorescence from the fluorochrome.

Cell standard plot

A linear correlation (r=0.999) between the fluorescence and cell numbers was
established in the range between 1.95 x 103 and 1 x 106 mononuclear leukocytes
(Figure 3). Higher number of cells was not tested since extreme high cell
concentration was not commonly used in laboratories.

Relative fluorescence enhancement values for neutrophils and mononuclear
leukocytes from the same or different individuals were found to be similar
(Figure 2b & 3). J774 cells gave much higher readings than the human primary cell
populations (Figure 2 & 3), reflecting the differences in nucleic acid contents. The
SD values derived from replicate samples were low. Calculated from the data of
three different experiments, the average of coefficients of variation (CV) was 2.87%,
ranging from 0.1 to 12.7%. The mean interassay CV was 5.05%, ranging between
1.7% and 11.4%. Errors in visual estimation of cells with hemacytometer may be a
major factor for the interassay variations.
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Figure 2. Fluorochrome concentration and fluorescence intensity. J774 cells (2a) and
neutrophils (2b) were stained with various concentrations of fluorochrome for 16-18 h
at room temperature. Coefficients of linear regression (r) are presented next to each
plot. Each point depicts the mean + SD of triplicate samples. Error bars, if not
shown, are masked by the symbols.
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Figure 3. Correlation between fluorescence intensity and quantity of mononuclear
leukocytes. Cells were serially diluted in PM and stained 16-18 h according the
protocol described in Materials and Methods. A linear correlation (r = 0.999) was
obtained between 1.95 x 103 to 1 x 106 cells. Each point depicts the mean ± SD of
triplicate samples. The small error bars are masked by the symbols. The insert
depicts RFU with lower cell counts.
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DISCUSSION

In this study, we compared three fluorochromes. All fluorochromes essentially
contain conjugated double bonds in ring structures. H33258 is a chain of ring
structures while EB and PI consist of clusters of rings. EB and PI are structurally
similar, but PI has a much larger side-chain (Haugland, 1992). All three
fluorochromes are charged molecules, and they tend to interact with SDS, an anionic
detergent. This is reflected in the interference of fluorescence by SDS as indicated in
Table I. Triton X-100 is a non-ionic detergent with a benzene ring. It interferes with
H33258 and EB, but not PI. The larger side-chain of PI may be responsible for
preventing the Triton X-100 molecules from interacting with the portion of PI
molecule that is essential for fluorescence property. PI and Triton X-100 were thus
chosen to develop this assay.

PI binds to both dsDNA and dsRNA. Double-stranded RNA can contribute from
negligible to 30-50% of the total amount of fluorescence, depending on the cell line
(Taylor & Milthorpe, 1980). In our assay, the contribution of dsRNA to the total
amount of fluorescence would probably be negligible, since EDTA chelates divalent
ions and decreases stability of RNA in double helical conformation without inducing
DNA denaturation. (Darzynkiewicz et al., 1975; Traganos et al., 1977).

EDTA can

also help unfold chromatins to expose more binding sites for the intercalating dye
(Vengerov & Popenko, 1977).
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DNA-PI complex is stable for at least 24 h at room temperature. Photobleaching
does not appear to be a problem (Krishan et al., 1978), and samples can be read
repeatedly. Some authors reported that high salt concentration increased DNAfluorochrome complex fluorescence, probably due to dissociation of DNA and
chromatin with improved exposure of DNA binding sites (Rago et al., 1990), but we
did not detect any significant enhancement (data not shown). This is probably
because EDTA, together with salt present in the medium, has already maximally
unfolded the chromatin structure for dye intercalation. The concentration of
fluorochrome needed for the assay depends on the cell type and concentration, i.e.
double-stranded polynucleotides present (West et al., 1985).

For fluorometric assays, serum-free culture media are usually recommended since
serum induces high values of background fluorescence for the fluorochromes used by
previous investigators (Bialek & Abken, 1991). Some substances in the culture media
as well as the cellular content can emit autofluorescence with excitation and emission
wavelengths common to many fluorochromes. However, since PI has a large Stokes
shift and long excitation and emission wavelengths, laboratory reagents do not create
a high background for PI fluorescence measurement. Since washing steps are not
required in this assay, variability between replicate samples is minimized.

The total amount of dsDNA and dsRNA varies at different phases of the cell
cycle and appears to correlate with proliferative activities (Frankfurt, 1980). This
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method takes advantage of a certain degree of asynchrony in cell cultures and the fact
that increases in the DNA are generally followed by cell division. However, this
fundamental assumption may be invalid in certain circumstances. For example, cells
may be induced to arrest at the G2 phase of the cell cycle (Palayoor et al., 1993;
Tounekti et al., 1993).

Each cell line requires its own cell standard curve to predict cell number from
fluorescence as dsDNA (Adams & Storrie, 1981; Papadimitriou & Lelkes, 1993) and
dsRNA content (Taylor & Milthoipe, 1980) per cell line can vary. For a given cell
line the results are highly reproducible and standard curves need not be set up for
every experiment. However, the assumption discussed above may be invalid, and
certain DNA-binding drugs can alter the fluorescence of Pi-stained cells (Krishan
et al., 1978). Cells suspended in different solutions will also produce different
readings.

PI is a known mutagen, and should be handled with care. However, disposal of
this substance is easy. PI may be removed from various solutions by filtration with
activated charcoal, which can then be incinerated. It can also be completely degraded
in buffer by reaction with sodium nitrite and hypophosphorous acid (Haugland, 1992).

The reagents for this assay are inexpensive and commercially available. Many
authors pointed to the cost of the microplate fluorometer (Papadimitriou & Lelkes,
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1993). Nonetheless, inexpensive machines which cost slightly more than an ordinary
spectro-fluorometer are recently available from several manufacturers. Moreover, the
microplate fluorometer is useful for many other techniques such as phagocyte
oxidative burst (Wan et al., 1993a), phagocytosis (Wan et al., 1993b), cytotoxicity
assays (Brenan & Parish, 1988; Essig-Marcello & van Buskirk, 1990), enzyme-linked
immunoassays, and protein assays. In a 96-well microtiter plate format, a large
number of samples can be rapidly measured, and the data captured by a computer can
be transferred directly to various programs for analyses.
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